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Abstract 
 
Human telomeric DNA terminates with a 3‟ single-stranded overhang 
containing tandem repeats of the sequence TTAGGG. These G-rich 
overhangs are prone to fold back to form G-quadruplex structures 
stabilized by consecutive G-tetrads each containing four guanines 
involved in Hoogsteen hydrogen bonds. G-quadruplex structures can 
inhibit the activity of telomerase, the enzyme that adds telomeric repeats 
to the ends of chromosomes and maintains the proliferation of cancer 
cells. Inhibition  of  telomerase  can  stop  tumour  growth  and  thus  
small  molecules  capable  to  interfere  with  telomere  maintenance 
inducing  the  formation  of  quadruplex  structures,  are  considered  to  
be  potential  anti-cancer  agents.  
In this perspective my thesis project concerns the characterization of the 
human telomeric DNA and aims to the study of new anti-telomerase 
agents that specifically bind telomeric DNA stabilizing the G-quadruplex 
structures.  
The first part of the thesis project concerns the study of π-π stacking 
ligands. The aim was to solve the nature of the binding mode and 
stoichiometry of the cationic porphyrin TMPyP4 to G-quadruplex 
structures. The cationic porphyrin TMPyP4 has been extensively studied 
as a quadruplex-binding ligand since it induces telomerase inhibition. A 
systematic study was performed, in dilute solution and under molecular 
crowding conditions, of the binding reactions between TMPyP4 and four 
different human telomeric G-quadruplexes structures. The results clearly 
indicate that all G-quadruplexes are able to bind up to four TMPyP4 
molecules. CD studies show that interaction with TMPyP4 promotes the 
conversion of the hybrid structures to an antiparallel conformation in 
dilute solution, while under molecular crowding conditions the 
interaction does not promote any conformational change. ITC reveals in 
both cases that the binding process comprises two sequential  events,  a  
first  one  in  which  one  molecule  of  TMPyP4 interacts with the 
quadruplex structures and second one in which three other molecules 
bind to the structures.  The selectivity of TMPyP4 for the quadruplex 
relative to duplex DNA was also investigated under molecular crowding 
conditions showing that TMPyP4 has enhanced selectivity for 
quadruplex DNA compared to the duplex structure. After then, taking 
into account that the 3'-terminal single-stranded human telomeric DNA  
is  actually 100-200 bases long and can form higher-order quadruplex 
structures, the binding of TMPyP4 with a longer telomeric sequence able 
to form two consecutive quadruplex units (multimer), was explored. The 
  
number of binding sites per quadruplex unit available  in the multimeric 
structure  is  smaller  than  the  one  expected  on  the  basis  of  the 
results  obtained  from  individual  quadruplex  binding studies, 
suggesting that the quadruplex units along a multimer structure do not 
behave as completely independent. The presence of adjacent 
quadruplexes results in a diverse binding ability not predictable from 
single quadruplex binding studies. The existence of quadruplex-
quadruplex interfaces in the full length telomeric overhang may provide 
an advantageous factor in drug design to enhance both affinity and 
selectivity for DNA telomeric quadruplexes.  
Another possible quadruplex drug studied in this thesis was the three 
side-chained triazatruxene derivative, termed azatrux. The binding of 
azatrux to the human telomeric G-quadruplex, was explored in presence 
of 40 % PEG 200 to simulate the crowding conditions existing inside the 
cell. The binding of azatrux to the tetramolecular parallel [d(TGGGGT)]4 
quadruplex and to another biologically relevant G-quadruplex (oncogene 
promoter c-Kit87up) and to duplex DNA in the presence and absence of 
crowding conditions was characterized.  The data indicate that azatrux 
binds in an end-stacking mode to the parallel G-quadruplex scaffold and 
highlights the key structural elements involved in the binding, showing a 
good selectivity for the human telomeric G-quadruplex over the other 
investigated DNA structures.  
The last part of the Ph.D. study was focused on the characterisation of 
groove binder ligands. The binding of a dicationic derivative of 
distamycin A (compound 1) with the [d(TGGGGT)]4 quadruplex were 
explored by isothermal titration calorimetry (ITC), and compared to the 
binding behaviour of netropsin to the same target. The experiments show 
that netropsin and compound 1 are able to bind to [d(TGGGGT)]4 with 
good affinity and comparable thermodynamic profiles. In both cases the 
interactions are entropically driven processes with a small favourable 
enthalpic contribution. Interestingly, the structural modifications of 
compound 1 decrease the affinity of the ligand toward the duplex, 
enhancing the selectivity. Furthermore the affinity of some new ligands 
with the grooves of DNA-quadruplex [d(TGGGGT)]4 were studied. 
These ligands were derivatives of a molecule obtained from a previous 
virtual screening study.  The interaction  has  been  evaluated,  analysing  
the  displacement of  these  ligands  from  the  grooves  of  DNA-
quadruplex  by   distamycin A,  the best groove binder identified until 
now, by means of isothermal titration  calorimetry (ITC). The 
competition ITC experiments performed, represent a possible strategy to 
evaluate the efficiency of a groove binder compared to distamycin A. 
The derivatives have been tested over double-stranded DNA to 
  
demonstrate whether there is an enhanced selectivity for quadruplex 
DNA compared to the duplex structure. 
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INTRODUCTION 
 
 
It was in the 1930 that telomeres (from the Greek telos = end and meros 
= part) were first recognized as essential structures at the ends of the 
chromosomes and were shown to be important for chromosomal stability. 
However, it was only in 1978 that the first telomeric sequence was 
identified  in the Tetrahymena, a single cell organism that at a certain 
stage of development has many identical minichromosomes with twice as 
many telomeres [1]. Today we know that telomeres, the ends of the 
chromosomes, are essential for chromosomal stability and integrity. 
Telomeres exist as DNA protein complexes in which telomeric DNA is 
packaged by a series of unique telomere proteins. 
Telomeres consist of many thousand repeats of the hexanucleotide 
TTAGGG giving rise to 4–15 kb of repetitive non-coding DNA in 
humans. Several kilobases of that sequence are paired with a 
complementary strand to form duplex DNA, but approximately 200 
nucleotides of the sequence remain unpaired and forms a single-stranded 
overhang (Figure 1). The single-stranded overhang of telomeres 
progressively shortens during the replication process because DNA 
polymerase cannot fully copy the ends of telomeric DNA at each 
replicative cycle. Human cells are estimated to have the potential to 
undergo on average 60–70 divisions, and at this point the cells growth 
arrest and enter senescence [2]. So the telomere can be considered as a 
biological clock, and shortens with age. 
Unfortunately integrity of telomeres in most cancer cells is maintained by 
the action of the telomerase enzyme complex, which catalyzes the 
synthesis of telomeric DNA repeats in order to replace those lost during 
replication. Telomerase is an enzyme overexpressed in ~80–85% of 
cancer cells and primary tumours [3,4], it maintains telomere length 
homeostasis acting as a tumour promoter. The catalytic subunit of 
telomerase (called hTERT in humans) has reverse transcriptase 
enzymatic activity and synthesizes TTAGGG repeats on the end of the 3‟ 
single-stranded overhang. 
 8 
 
 
 
Figure 1 Fluorescent hybridization in situ showing human telomeres. The green spots 
mark the telomeres (adapted from ref. 5). 
 
 
 
The G-rich telomeric overhang is able to fold in unusual DNA structures, 
called G-quadruplex and stabilized by consecutive G-tetrads each 
containing four guanines involved in Hoogsteen hydrogen bonds [6]. It 
has been shown that the folding of the single-stranded telomeric DNA 
into a four-stranded G-quadruplex structure inhibits the enzyme‟s 
catalytic activity [7]. Inhibition of telomerase can stop tumor growth, and 
thus small molecules that induce the formation of quadruplex structures 
by binding to them are considered to be potential anticancer agents. In 
order to optimize the design of new anticancer agents, in my Ph.D thesis, 
the structural and energetic aspects of the binding of several small 
molecules to G-quadruplex structures formed by DNA telomeric 
sequences have been explored. In the study, all the known human 
telomeric quadruplex topologies were employed. Further, taking into 
account that the 3'-terminal single-stranded human telomeric DNA is 
100-200 bases long, a longer telomeric sequences able to fold in more 
quadruplex units was also employed. Lastly, in order to mimic more 
closely the physiological conditions, the effect of crowding on the human 
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telomeric G-quadurplex structure and binding properties was also 
explored.  
The obtained results provides new insights to understand the binding 
properties of the human telomeric quadruplex structures and could be 
useful for future optimization of new anti- telomerase, anti-cancer drugs. 
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CHAPTER 1  G-quadruplex structures as anti-
telomerase targets 
 
 
 
 
 
1.1. Telomere and Telomerase 
 
Telomeres exist as DNA-protein complexes in which telomeric DNA is 
packaged by a series of unique telomere proteins. Human telomeric DNA 
contains tandem repeats of the sequence TTAGGG and in all eukaryotic 
cells the telomeric region is double-stranded for most of its length, but 
the extreme 3′-end consists of single-stranded G-rich DNA overhangs 
approximately 200 nt in length. 
The TTAGGG repeats of human telomeres are associated with the six-
protein complex shelterin (Figure 1.1). Three shelterin proteins, TRF1, 
TRF2, and POT1, directly recognize telomere DNA sequences, and are 
interconnected by three additional shelterin proteins, TIN2, TPP1, and 
Rap1.  
Telomeric repeat-binding factors 1 and 2 (TRF1 and TRF2) directly 
bind the TTAGGG sequences in double-stranded telomeric DNA by a C-
terminal DNA binding domain [8,9]. 
Protection of telomeres 1 (POT1) directly binds the single stranded 
overhang of the chromosome end in its N-terminus [10]. The single-
stranded DNA-binding domain in the N terminus allows the proteins to 
bind to arrays of the sequence TAGGGTTAG with great sequence 
specificity. It has been suggested that POT1 is able to disrupt the highly 
folded intramolecular G-quadruplex structures [11]. 
TRF2- and TRF1-interacting nuclear protein 2 (TIN2) bridges TRF1 
and TRF2 to the TPP1–POT1 heterodimer linking the duplex component 
of the telomeres to the single-stranded overhang [12,13]. 
Repressor/Activator protein 1 (Rap1) lacks DNA binding activity in 
human and is dependent on its interaction with TRF2 for telomere 
binding [14,15]. 
TIN2 and POT1 interacting protein 1 (TPP1) interacts with POT1 and 
TIN2 by the POT1-binding domain and C-terminal of TIN2 [16]. The 
connection with TPP1 is critical for the association of POT1 with 
telomeres, providing a main way by which POT1 is recruited to 
telomeres [17,18]. Several telomeric DNA-binding proteins have been 
found to associate with telomere G-quadruplex. POT1 is known to 
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disrupt the telomeric G-quadruplex, allowing for telomerase extension 
[19]. Conversely, Rap1 is believed to bind telomeric DNA to promote G-
quadruplex formation [20], whereas human RaP1 is recruited to 
telomeres by TRF2. Taken together, the shelterin complex, despite 
consisting of only six proteins, has an immensely complex role in 
telomere regulation and protection and in the control of signaling 
cascades from the chromosome ends.  
 
 
 
 
Figure 1.1 Human telomeres associate with the six-protein complex shelterin (adapted 
from ref. 5) . 
 
 
 
Telomerase is the enzyme implied in maintaining the telomeric DNA 
length at the ends of chromosomes. When the telomerase is not 
operative, chromosomes are progressively eroded after each cell 
replication until a critical state of replicative senescence is reached, with 
no further replication, and cell death occurs [21]. Telomerase is active in 
about 85% of cancer cells, thus favouring their immortalization [22,23]; 
it is inactive in normal somatic cells, and active in germ and stem cells 
with regenerative potential [24]. Human telomerase is a 
ribonucleoprotein complex containing two major components as well as 
many associated proteins that are critical for function. The first major 
component is the hTERT (human Telomerase Reverse Transcriptase), a 
reverse transcriptase catalytic subunit; the second component is the hTR 
(human Telomerase RNA), an RNA subunit [25,26]. hTERT is a 120 
kDa protein, active as a dimer [27], that interacts with telomeric DNA 
and telomere-binding protein [28,29]. The interaction of hTR with 
hTERT determines the catalytic activity [30,31]. Telomerase uses its 
internal RNA component, complementary to the telomeric single-
stranded overhang, as a template for the synthesis of telomeric TTAGGG 
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repeats directly onto the ends of chromosomes. The enzyme adds the first 
six bases, then translocates the template RNA for the synthesis of the 
next six bases (Figure 1.2) [32]. This extension at the 3′-end of the DNA 
template compensates for telomere shortening that results from nuclease 
action and incomplete terminal DNA replication. A multi component 
“telomere homeostasis” system promotes this telomeric extension when a 
telomere becomes shortened, thus making telomeric repeats accessible to 
the telomerase [29]. 
Hence, cancer cells maintain telomere length because telomerase assures 
the addition of telomeric repeats to chromosomal ends. These cells have 
high telomerase activity whereas somatic cells do not [33,34]. These 
findings are the base for the evaluation of telomerase inhibitors as 
potential anticancer agents [35,36,37].  The aim is to preserve from toxic 
side effects normal cells, which do not express the telomerase [38]. 
Different telomerase inhibitor strategies exist, based on targeting the 
different telomerase components or inhibiting telomerase activity.  
 
 
 
 
Figure 1.2 Telomerase reaction cycle. In every reverse transcription cycle, the enzyme 
adds six bases, and then translocates the template RNA for the synthesis of the next six 
bases. 
 
 
 
Numerous approaches have been developed, including the targeting of 
the two major components hTERT and hTR of telomerase, and the 
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telomeres themselves (Figure 1.3). A possible approach is to design and 
synthesize drugs able to bind and stabilize the folding of the telomeric 
DNA G-rich overhangs into G-quadruplex structures (Figure 1.3) [7]. 
 
 
 
 
 
Figure 1.3  Inhibition mechanisms of telomerase (adapted from ref.5). 
 
 
 
G-quadruplex structures were detected in vivo at the ends of human 
chromosomes through the use of a titrated ligand that binds specifically 
to quadruplex DNA [39] and through detection using a fluorescent 
carbazole derivative that binds selectively to quadruplex structures [40]. 
Additionally in 1991, Zahler and coworkers found that folding of a 
telomeric  G-rich  single  strand  in  a  DNA  quadruplex  structure  
inhibits  in  vitro telomerase activity [7]. Hence, G-quadruplex structures 
within the telomere could effectively inhibit telomerase by blocking its 
binding to its substrate DNA and preventing elongation during 
replication. The development of new G-quadruplex ligands, as possible 
anticancer drug, has been the main focus of this Ph.D. thesis. A detailed 
structural knowledge of the G-quadruplex structures (the target 
structures) is critical for structure-based drug design and thus has been 
the subject of intense investigation.  
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1.2. General structural features of G-quadruplex 
 
G-quadruplexes are higher-order DNA and RNA structures formed from 
G-rich sequences that are stabilized by tetrads of hydrogen-bonded 
guanine bases (G-quartets) [41]. Stacking of G-quartets and coordination 
of metal cations, preferentially Na
+
 and K
+
, between two adjacent G-
quartet planes yield a stable G-quadruplex structure (Figure 1.4) [42]. 
 
 
 
 
Figure 1.4 Schematic representation of the G-quartet and G quadruplex. 
 
 
 
G-quadruplexes can be formed from one, two or four separate G-reach 
strands of DNA (or RNA) and can display a wide variety of topologies, 
which are in part a consequence of various possible combinations of 
strand direction, as well as variations in loop size and sequence. They can 
be defined in general terms as structures formed by a core of at least two 
stacked G-quartets (or G-tetrads), which are held together by loops that 
are not involved in the quartets themselves. The G-quartet consists of a 
planar arrangement of four guanine bases associated through a cyclic 
array  of  Hoogsteen-like  hydrogen  bonds  in  which  each  guanine  
base  both  accepts  and  donates  two  hydrogen  bonds  (Figure 1.4).  
The G-tetrads are not stacked linearly, but adopt a right-handed helix. 
The combination  of  the  number  of  stacked  G-quartets,  the  polarity 
of  the  strands  and  the location and length of the loops lead to a 
plurality of G-quadruplex structures. G-quadruplexes can be classified on 
the basis of: 1) the number of strands (one, two or four); 2) the pattern of 
strand orientation (parallel, antiparallel); 3) the conformation of guanine 
glycosidic torsion angles (anti or syn); 4) the orientation of the loops 
(lateral, diagonal or propeller) [43]. 
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The G-tetrad core can be classified with regard to two mutually related 
factors, the relative orientations of the strands and the glycosidic 
conformations [anti (Figure 1.5B) or syn (Figure 1.5C)] of guanines, 
which in turn define specific patterns of groove dimensions.  
 
 
 
 
 
Figure 1.5  (A) G-tetrad alignment. (B,C) Guanine in (B) anti and (C) syn glycosidic 
conformations. (D, E) Schematic presentation of a G-tetrad (D) each guanine shown as 
a rectangular and (E) the G-tetrad shown as a square (adapted from ref. 44). 
 
 
 
There are four different possibilities for the relative strand orientations in 
the G-tetrad core (Figure 1.6 A–D): (a) four strands are oriented in the 
same direction (designated a parallel-stranded core) (Figure 1.6 A); (b) 
three strands are oriented in one direction and the fourth in the opposite 
direction [designated a (3 + 1) core, also called a hybrid core in the 
literature] (Figure 1.6 B); (c) two neighbouring strands are oriented in 
one direction and the two remaining strands in the opposite direction 
(designated an up–up–down–down core, also called an antiparallel-
stranded core in the literature) (Figure 1.6 C); and (d) two strands across 
one diagonal are oriented in one direction and the two remaining strands 
across the other diagonal in the opposite direction (designated an up–
down–up–down core, also called an antiparallel-stranded core in the 
literature) (Figure 1.6 D). The glycosidic conformations of guanines 
within a G-tetrad are geometrically associated with the relative strand 
orientations. The hydrogen-bond directionality of a G-tetrad in the core 
can be clockwise or anticlockwise, and this is directly related to the 
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glycosidic conformations of guanines for each type of strand orientations. 
The stacking patterns between adjacent G-tetrads of the same hydrogen-
bond directionality differ from those between adjacent G-tetrads of 
opposite hydrogen-bond directionalities [44]. 
 
 
 
 
 
Figure 1.6   (A–D) Four types of G-tetrad cores: (A) parallel G-tetrad core, (B) (3 + 1) 
G-tetrad core, (C) antiparallel G-tetrad core (up–up–down–down) and (D) antiparallel 
G-tetrad core (up–down–up–down). (E–G) Three types of loops (colored red): (E) 
diagonal loop, (F) edgewise loop and (G) double-chain-reversal loop. Arrows indicate 
the strand orientations, from 5′ to 3′ direction (adapted from ref.44). 
 
 
 
When one or more G-tetrads are stacked, a cylindrical central cavity is 
produced [45]. This cavity, lined with the guanine O6 carbonyl oxygens, 
forms a specific binding site for metal ions [46]. The coordination of 
potassium [47], sodium [48], and strontium [49] all provide both 
thermodynamic and kinetic stability to the G-quadruplex structure. 
Experiments demonstrate that the G-quadruplex is stabilized by the alkali 
series in the following order: K
+
>>Na
+ 
>Rb
+
>NH4
+
>Cs
+
>>Li
+
, and for 
the alkaline earth series in the order: Sr
2+ 
>>Ba
2+ 
>Ca
2+
>Mg
2+ 
indicating 
that the atomic radii of 1.3 Å of potassium and strontium fit best in the 
coordination site between adjacent G-tetrads [50]. The precise location of 
the cations between the tetrads is dependent on the nature of the ion. Na
+
 
ions within the channel have been observed in a range of geometries; in 
some structures, a Na
+ 
ion is in plane with a G-tetrad whereas in others it 
is between two successive G-tetrads. K
+
 ions are always equidistant 
between each G-tetrad plane, interacting equally with each of eight 
carbonyl oxygens in a bipyramidyl antiprismatic coordination geometry 
[51]. 
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All quadruplex structures have four grooves, defined as the cavities 
bounded by the phosphodiester backbones. A consequence of variations 
in the glycosidic torsion angles is the altering of the spacing between the 
DNA strands of the G-quadruplex, resulting in varying groove-widths 
along the side of the quadruplex [52]. In cases where a guanosine in the 
syn conformation donates hydrogen bonds to a neighboring guanosine in 
the anti conformation, the groove formed between the two is extremely 
narrow, with a phosphate to phosphate distance as small as 7-9 Å [53]. In 
contrast, when the hydrogen bonding polarity between adjacent syn- and 
anti-guanosines is reversed, a very wide groove is formed [53]. An 
intermediate width groove results when adjacent guanosines adopt the 
same glycosidic conformation [53]. Indeed, in a parallel four-stranded 
quadruplex, where all the guanine bases are in the anti conformation, the 
four grooves are approximately the same medium width. For example, in 
a symmetric bimolecular structure having lateral loops, the G-tetrads are 
formed from guanosines of alternating anti-syn-anti-syn conformation, 
with each syn-guanosine donating hydrogen bonds to an adjacent anti-
guanosine, and accepting hydrogen bonds from the other adjacent 
guanosine [54]. This results in a rectangular G-tetrad core with grooves 
of alternating wide-narrow-wide-narrow widths. In contrast, a 
bimolecular quadruplex with diagonal loops, has guanosines that adopt 
the syn-syn-anti-anti conformations, which results in G-tetrads that adopt 
a parallelogram arrangement and the formation of alternative wide, 
medium, narrow, medium width grooves between strands. 
Groove dimensions are then variable, and depend on overall topology 
and the nature of the loops. Grooves in quadruplexes with only lateral or 
diagonal loops are structurally simple, but, in contrast, grooves that 
incorporate propeller loops have more complex structural features that 
reflect the insertion of the variable-sequence loops into the grooves. 
 
 
 
 
 
1.3. Human telomeric G-Quadruplex 
 
The rational design of G-quadruplex-binding drugs requires knowledge 
of the detailed structures of the intramolecular human telomeric G-
quadruplexes to be successful in a potential anticancer therapy.  In this 
perspective extensive researches have been dedicated to G-quadruplex 
structures formed by human telomeric DNA.  Several native structures, 
formed by human telomeric G-quadruplex sequences, have been 
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determined by both NMR and X-ray techniques [55,56,57]. Interestingly, 
it has been shown that the conformation of the intramolecular human 
telomeric G-quadruplexes is dependent upon the type of counter ions and 
the presence of flanking bases. An antiparallel basket conformation was 
found for human telomeric d[AGGG(TTAGGG)3] sequence in Na
+
 
containing solution (Figure 1.7F) [55]. A hybrid-type conformation, the 
so-called (3+1) mixed conformation, appears to be a major form for 
various human telomeric oligonucleotides in solution in the presence of 
K
+
 [58,59]. Depending on the flanking segments, those telomeric 
sequences can form two distinct but related hybrid-type structures, 
known as hybrid-1 or Form 1 (Figure 1.7H) and  hybrid-2 or Form 2 
(Figure 1.7I) [60,61]. It has been shown that some human telomeric 
sequences are in equilibrium between hybrid-1 and hybrid-2 structures in 
K
+
 solution, which is largely determined by the 3‟-flanking sequence. 
The hybrid-2 type structure appears to be a plausible conformation for 
the extended human telomeric sequences [61]. The structure of a new 
intramolecular G-quadruplex conformation formed by the human 
telomeric d[(GGGTTA)3GGGT] sequence in K
+
 solution has recently 
been reported (Figure 1.7J). This is an antiparallel basket-type G-
quadruplex involving only two layers of G-tetrads ( Form 3) and has 
been reported to be of greater stability than the two hybrid forms [57]. 
The parallel form has been observed in the crystal structure of the four-
repeat sequence d[AGGG(TTAGGG)3] in K
+
 (Figure 1.7G) [62], and 
may be present in more crowded solution conditions, such as in a cell 
nucleus [63].  
G-quadruplex structures determined for human telomeric DNA 
sequences show different configurations for TTA loops in various 
contexts involving three G-tetrads, as well as GTTA and GTTAG loops 
in Form 3 involving two G-tetrads. Base pairing and stacking are 
generally observed in these loops [64,65]. It has been suggested that 
these loops are dynamic and may be good targets for specific ligand 
recognitions [66,67]. 
In summary, the crucial information provided by all the structural studies 
is that the particular DNA sequences and the solution conditions 
employed are relevant in determining the structure observed. Hence to 
determine the most physiological relevant human telomeric DNA 
structures, studies must be performed with DNA in experimental 
conditions mimicking more closely the living cellular environment. On 
this regard, two points should be considered: 1) that the full length 
telomeric DNA is much longer than the short DNA sequences commonly 
employed in the biophysical studies and can, in principle, form more than 
one consecutive quadruplex unit [68,69,70], 2) the cellular environment 
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is “crowded”  with other biomolecules and the behavior of the telomeric 
DNA in this “crowding conditions” could be significantly different from 
the one in the buffers, commonly employed in laboratory experiments 
(also called “dilute conditions”). 
 
 
 
 
 
Figure 1.7   Schematic structures of G-quadruplexes. (A) Tetrameric parallel-stranded 
G-quadruplex [71]. (B) Dimeric parallel-stranded G-quadruplex [72], (C) Dimeric 
antiparallel-stranded G-quadruplex [72]. (D) (E) Asymmetric dimeric (3+1) G-
quadruplex [73]. (F) Basket-type form [55]. (G) Propeller-type form [62],  (H) (3+1), 
Form 1 observed for d[TA(GGGTTA)3GGG] in K
+
 solution. (I) (3+1) Form 2 observed 
for d[TA(GGGTTA)3GGGTT] in K
+
 solution [59]. (J) Basket-type form observed for 
d[(GGGTTA)3GGGT] in K
+
 solution [57]. anti guanines are colored cyan; syn 
guanines are colored magenta; loops are colored red. M, N and W represent medium, 
narrow and wide grooves, respectively (Adapted from ref.44). 
 
 
 
1.3.1. Structures of longer DNA telomeric sequences 
 
Structural studies on human telomeric DNA has been mainly performed 
employing four-repeats telomeric sequences, little is known about the 
structure of longer DNA telomeric sequences. However, it might be more 
biologically relevant to take into account the real length of the 3‟-
terminal single-stranded overhang of human telomeric DNA in vivo 
(100–200 nt). The telomeric single-stranded overhang is actually 
constituted by tens of TTAGGG repeats and, a growing evidence exists 
that it forms several consecutive quadruplex structures (multimers) in the 
overhang region [67,69,74,75,76,65]. Recently, G-quadruplexes were 
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visualized at the end of telomeres by atomic force microscopy (AFM) 
[76]. The AFM image shows blob-shaped protrusions arranged end-to-
end, suggesting the presence of adjacent G-quadruplex units (Figure 1.8) 
[58]. The formation of two contiguous quadruplex in the 
GGG(TTAGGG)8 DNA telomeric sequence and its RNA analogous has 
been recently demonstrated on the basis of ESI–MS experiments [77].  
Several models have been proposed regarding the arrangements of these 
G-quadruplex blocks [69]. In one model, G-quadruplex blocks are 
arranged like „beads-on-a-string‟ [69], they can move relatively 
independently of each other and are constrained only by the connecting 
linkers. Alternatively, G-quadruplex blocks can stack on each other to 
form a higher order structure. Different multimeric structures have been 
proposed for the longer DNA telomeric sequences depending on the type 
of quadruplexes involved in the multimers and on the kind of interactions 
between the quadruplex units. Neidle and coworkers proposed, on the 
basis of a computational study, a multimeric model formed by 
consecutive quadruplex units in all-parallel-stranded topology from the 
observed crystal structure of the four-repeat sequence 
d[AGGG(TTAGGG)3] in K
+
 [67]. Later Petraccone et al. have suggested 
that multimeric structures could be easily formed by quadruplex units 
with the mixed-type G-quadruplex topology (called  “Hybrid-1” and  
“Hybrid-2”  or  “Form-1”  and  “Form-2”) on the basis of NMR 
structures observed for d[TA(GGGTTA)3GGG] [62]. (I) (3+1) and 
d[TA(GGGTTA)3GGGTT] in K
+
 solution [59] (right side Figure 1.8) 
[78,65].  In  further  support  of  this hypothesis, it has been proposed a 
dimeric model for the (TTAGGG)8TT telomeric sequence consisting of 
two consecutive mixed-type quadruplexes, one having the Hybrid-1 
conformation and the other having the Hybrid-2 conformation, this 
model has been validated experimentally [69,79]. 
Despite the increasing number of structural information on longer DNA 
telomeric sequences, very few data are available on the binding 
properties of these sequences compared with the shorter DNA telomeric 
sequences. However, the existence of quadruplex-quadruplex interfaces 
in the longer telomeric sequences could be a predominant factor in 
determining the recognition properties of the telomeric DNA and the 
results of binding studies performed on single quadruplex may not be 
necessarily useful to predict the binding properties of multimeric 
structures. To address this question, in this Ph.D. thesis, were compared 
the binding properties of multi-quadruplex structures with the one of the 
single quadruplex structures (dicussed in chapter 3). 
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Figure 1.8 AFM image of higher-order telomeric DNA structures (left side), human 
telomeric DNA, Hybrid-12 model [64] (right side). 
 
 
 
 
1.3.2. G-quadruplex under molecular crowding conditions 
 
Biomolecules have evolved to function within living cells, which contain 
a variety of macromolecules including nucleic acids, proteins, 
polysaccharides, and metabolites. These molecules make the intracellular 
environment extremely crowded, so becomes of biological interest to 
study biochemical reactions in systems that simulate the living 
environment that contain substantially a total concentration of ~400 
mg/ml of macromolecules in solution [69,80,81] 
It has been reported that molecular crowding is a critical factor 
determining the structure, stability and function of  nucleic acids [63]. 
Recent studies have raised significant controversy regarding the exact 
structure of the quadruplex formed by human telomeric DNA in a 
physiological relevant environment. Particularly, it has been reported 
thatdifferent G-quadruplex conformations are converted to a propeller-
type parallel-stranded G-quadruplex in K
+
 containing crowded solution 
due to water depletion [82]. Human telomeric G-quadruplexes have been 
studied in different molecular agents such as putrescine, cadaverine, 
spermine, glycerol, and polyethylene glycol [83,84]. The most common 
crowding agent is polyethylene glycol (PEG 200). PEG is a neutral 
polymer and does not interact with G-quadruplex because the interaction 
is thermodynamically unfavorable. The volume occupied by PEG grows 
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large as it is added increasingly, therefore, excluded volume could be the  
major factor inducing quadruplex structure [85].  
Molecular crowding plays an important role in the regulation of human 
telomeric G-quadruplexes conformation, for this reason becomes very 
important to perform binding studies in solution conditions that more 
closely mimic the cell environment. 
 
 
 
 
 
1.4.  G-quadruplex ligands 
 
G-quadruplex stabilizing compounds have recently received increased 
interest due to their potential application as anticancer therapeutics, 
substantial efforts have been made to design synthetic compounds that 
could lock or induce telomeric DNA in a G-quadruplex conformation and 
prevent telomere elongation.  Recently a large number of small 
molecules (G-quadruplex ligands or G4-ligands), have been designed 
[86,87,88]. 
A desired ligand would recognize a G-quadruplex structure formed by 
human telomeric sequences with high affinity and specificity.  Different 
G-quadruplex recognition modes are possible: (a) stacking on the ends of 
the G-tetrad core, (b) groove binding, (c) taking place of one or more 
strands in the core, (d) interacting with the backbone (core and loops), 
and (e) interacting with the loop bases. Many of the reported G-
quadruplex ligands contain planar aromatic rings [89,90], which can 
interact with human telomeric G-quadruplex by stacking on the terminal 
G-tetrads. In addition to the end-stacking binding mode of the aromatic 
rings, some ligands also contain other moieties that can recognize loops 
by stacking with loop bases or forming intermolecular hydrogen bonds 
[89,90,91] or recognize the backbone with electrostatic interactions 
[92,93]. 
(π)-stacking ligands: For efficient stacking, these ligands should possess 
a large aromatic surface, much larger than duplex binders, for efficient 
aromatic–aromatic overlap and selectivity. In addition, the ligands must 
exhibit reasonable water solubility, usually achieved by incorporating 
side chains around the aromatic core, which can be protonated. The side 
chains also contribute to the stability of quadruplexes by establishing 
electrostatic interactions with atoms in grooves and central channel [94]. 
Groove/loop binding ligands: There are significant chemical and 
conformational differences between quadruplex and duplex grooves and 
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therefore recognition of these grooves by ligands is expected to provide 
higher quadruplex vs. duplex selectivity. Distamycin A is the only 
compound for which groove binding has been proved until today. 
Martino et al. investigated the interaction of distamycin A with 
d[TGGGGT]4 and found that the ligand binds with a 4/1 ratio to the 
quadruplex as a dimer in an anti-parallel fashion [95]. Using the above 
principles, should be relatively easy to design compounds that bind G-
quadruplexes, although not necessarily with high affinity and more 
importantly selectivity  (ability  to  interact  only  with  quadruplex  DNA  
and  not duplex  DNA).  
 
 
 
 
 
1.5. Thesis purpose 
 
Despite a wealth of current knowledge about human telomeric G-
quadruplexes, there remain many challenges associated with the structure 
and molecular recognition in the human telomeres.  
These include: (a) the structure and dynamics of all possible DNA G-
quadruplexes formed by short and long human telomeric sequences; (b) 
the structural basis for molecular recognition of human telomeric G-
quadruplexes by different small molecules and (c) the detection of G-
quadruplex structures and conformational transitions in the human 
telomeres in the physiological environment of living systems.  
The general purpose of this thesis was to study the binding proprieties 
between different topologies of DNA G-quadruplex and selected ligands 
in different buffer conditions. 
The energetic of the interaction with different sequences of human 
telomeric DNA with cation  porphyrin  TMPyP4  and  three  side-chained 
triazatruxene derivative, was explored.  
Additionally the interaction between the truncated sequence of 
Tetrahymena telomeric DNA, d(TGGGGT), which forms a 
tetramolecular quadruplex in solution, was explored with new groove 
binder  ligands like distamycin  A  derivatives  and new virtual  screening  
derived  compounds. 
Lastly  the  binding  properties  of the selected ligands  have been studied 
over  other  biologically relevant DNA structures, in order to verify, 
whether there is, an enhanced selectivity for human telomeric 
quadruplexes over the others [96,97,98,99]. 
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The binding stoichiometry and the thermodynamic parameters related to 
the association processes, have been studied by means of isothermal 
titration calorimetry (ITC) and other spectroscopic techniques such as 
circular dichroism, fluorescence spectroscopy and UV-vis spectroscopy, 
in order to understand the overall nature of the forces that drove the 
binding reactions and to get more insight into the structural aspects of 
binding.  
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CHAPTER 2 Methods 
 
 
A wide variety of techniques are employed to study interactions of 
ligands with G-quadruplex DNA. These methods vary from simple 
methods, used for evaluating properties like ligand affinity, to more 
sophisticated methods, used for obtaining kinetic, thermodynamic, 
stoichiometric and conformational data for structure–activity relationship 
studies. The key challenge in G4-ligand design is to make the ligand 
selective for quadruplex structures in comparison to duplex DNA and the 
biophysical and biochemical method being used to investigate these 
interactions should be able to detect and measure the ligand selectivity 
for quadruplexes over duplexes or other secondary structures. Because of 
high degree of structural polymorphism in quadruplexes, it is important 
to determine binding sites of the ligand and its mode of interaction. Each 
technique has its own advantages and disadvantages and usually more 
than one method is needed to obtain complete information about 
quadruplex DNA/ligand interactions. The methodology and experimental 
procedures applied in this thesis are, essentially, belonging to two 
different families 
 
 Spectroscopic techniques 
 Calorimetric techniques 
 
The techniques belonging to the first family, like UV-visible (UV-Vis), 
fluorescence and circular dichroism (CD) spectroscopy are rapid methods 
and require small amounts of material. These techniques allow to 
investigate on the conformational proprieties of the studied 
macromolecules. On the other hand the techniques belonging to the 
second family allow the study of the energetics aspects of the studied 
interactions.  
 
 
 
 
2.1. Isothermal Titration calorimetry 
 
Isothermal titration calorimetry (ITC) is a valuable tool for characterizing 
interactions of G-quadruplexes with other biomolecules, including small 
ligands, thanks to its general applicability and precision [100,101]. ITC is 
a high-accuracy method for measuring binding affinities and 
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stoichiometry; moreover, it is the only technique that directly measures 
the binding enthalpy. ITC also allows dissecting the free energy of 
binding into enthalpic and entropic components to reveal the overall 
nature of the forces that drive the binding reaction [102,103].  In ITC, 
one component of a complex (such as DNA or a protein) is present in the 
calorimeter‟s sample cell, and the second component (for example, a 
drug) is slowly added in an incremental, stepwise fashion. Since all 
binding events are accompanied by the evolution or absorption of heat (a 
change in enthalpy), the analysis of these extremely small thermal effects 
arising from the binding allows a full thermodynamic characterization of 
the reaction and provides fundamental information about the molecular 
interactions driving the process. The calorimeter used in the experiments 
is the CSC 5300 nano ITC III TA Instruments.  
The calorimeter holds two vessels (reference and sample cells), with a 
nominal volume of 1.0 ml. The reference vessel contains water or buffer 
solution, the sample vessel holds a solution containing one of the 
reactants. The two vessels are constantly kept in thermal equilibrium 
with the bath during the experiment. The heat flow between the reaction 
vessel and the isothermal block is precisely measured by thermoelectric 
device sensors that surround the vessel and is monitored as a function of 
time. The nano ITC uses a differential power compensation design for 
maximum sensitivity and responsiveness. Semiconducting thermoelectric 
devices (TED) are used for temperature control as well as to detect 
temperature differences between the sample and reference cell. A 
computer controlled PID (a proportional–integral–derivative controller) 
loop uses a heater on the sample cell to maintain a zero temperature 
difference between the sample and the reference cell. The ITC measures 
the heat generated/absorbed when two solutions of reactants are mixed.  
 
 
 
Figure 2.1  Schematic representation of a CSC Model 5300 nano ITC III. 
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The power required to maintain the zero difference between the cells 
represents the calorimeter signal and is monitored as function of time. If 
a reaction occurs, the sample cell produces heat, the heat required to 
maintain the zero difference decreases by the amount of heat supplied by 
the reaction, resulting in a peak in the thermogram. A typical experiment 
consists of several injections spaced minutes apart, resulting in several 
peaks in the thermogram. The reactant is contained in a precision syringe 
(25-250 μl) connected to the sample cell and is added in computer-
controlled injections (1-20 μl). The titrant syringe needle also functions 
as the stirrer and extends down into the reaction vessel from the top when 
the burette is mounted. The nano ITC can detect heat effects as small as 
0.4 milli Joule, allowing titrations to be done with nanomoles of 
biopolymer, ITC may be run at any temperature between 0 and 110°C. In 
a typical ligand-macromolecule titration, the chemical reaction generated 
by each injection either releases or absorbs a certain amount of heat (qi) 
proportional to the amount of ligand that binds to the macromolecule in a 
particular injection (V×ΔLi) and to the characteristic binding enthalpy 
(ΔH) for the reaction: qi= V × ΔH × ΔLi where V is the volume of the 
reaction cell and ΔLi is the increase in the concentration of bound ligand 
after the i
th
  injection [104]. The heat after each injection is therefore 
obtained by calculating the area under each peak. Because the amount of 
uncomplexed macromolecule available progressively decreases after 
each successive injection, the magnitude of the peaks becomes 
progressively smaller until complete saturation is achieved. Once 
saturation is reached, subsequent injections produce similar peaks 
corresponding to dilution or constant mechanical effects that need to be 
subtracted from all the injection peaks before analysis. The top panel of 
Figure 2.2  depicts the signal produced by the sequence of injections, and 
the bottom panel shows the data after integration of each injection peak. 
The sigmoidal shape of the bottom panel (Figure 2.2), with numerous 
data points throughout the curved rise portion of the plot, facilitates 
estimation of the midpoint of the transition, and thus the stoichiometry of 
the binding reaction (in this case, 1:1). Kb and ΔH are calculated by 
iterative approximation. 
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Figure 2.2 (a) Signal produced by the sequence of injections for a typical ITC 
experiment. (b) Data after integration of each injection peak. 
 
 
 
A value for Kb is initially estimated, and then the concentration of bound 
complex is calculated for each injection. In combination with the 
measured heat, these values are used to determine the average of ΔH. 
The ΔH and the calculated concentration are then used to determine an 
expected heat per injection, and the error square sum between the 
measured and expected heat for each peak is calculated. The value of Kb 
is then adjusted and the process repeated until a minimum error square 
sum is obtained.  
The values of Kb, ΔH and n (stoichiometry) can often be calculated from 
a single experiment as long as the concentration of both macromolecule 
and ligand are accurately known [105] and chosen so that:  
 
10 <Kb [M]T< 1000 
 
where [M]T is the total concentration of macromolecule in the sample 
cell titrated by ligand [106]. If concentrations are not within this range, 
the curvature of the titration plot can be so low as to be almost linear, or 
so high as to produce a step-like profile. In these cases Kb may not be 
estimated accurately. Typically, macromolecule concentrations in the 
order of 10-100 μM are used, permitting Kb values in the range 10
2–109 
M
-1
 to be accurately estimated.  
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Since temperature (T) is held constant throughout the entire 
experiment, the free energy (ΔG°) of the binding reaction can be 
determined by:  
 
ΔG° = -RTlnKb 
 
where R is the gas constant.  
ITC directly measures ΔH°, so the change in entropy (ΔS°) can be 
determined by:  
 
ΔS° = (ΔH° – ΔG°) / T 
 
Quantification of these thermodynamic parameters reveals the physical 
processes involved in the binding reaction. A spontaneous binding 
process must have a negative ΔG°, and ΔG° will become increasingly 
negative as binding becomes tighter. As seen above, free energy changes 
have both an enthalpic and entropic component. The enthalpic 
contribution to binding is primarily due to an increased number of 
hydrogen bonds at the ligand-target interface, and to more favorable van 
der Waals interactions between the two interacting molecules; the 
hydrophilicity of the system will determine how important electrostatic, 
polar and dipolar interactions will be in driving the reaction. The entropic 
contribution has two primary components: conformational changes, such 
as folding or unfolding of the macromolecules, and the release of bound 
solvent as hydrophobic groups interact. The large number of ordered 
water molecules released into the bulk solvent when the hydrophobic 
surfaces of the ligand and target interact provides the main driving force 
for hydrophobic interactions. This driving force is sufficient to 
compensate for the unfavorable conformational entropy of the 
macromolecule and ligand caused by decreased conformational and 
rotational freedom following binding. In addition to the entropic effect, 
burial of surface area also affects the heat capacity of the sample, since 
water molecules ordered at hydrophobic surfaces have a different heat 
capacity from that of water that has been released into the bulk solvent 
following binding.  
Of paramount importance when conducting ITC experiments with 
nucleic acids is sample preparation. It is now routine to obtain large 
amounts of synthetic DNA from commercial suppliers. However it is 
very important to make sure that the sequence has been subject to 
purification by HPLC or capillary electrophoresis to ensure that the 
sample is better than 99% pure. The presence of contaminating 
sequences from the synthesis will yield erroneous data in the ITC 
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experiment, especially in terms of stoichiometry if there is competitive 
binding to the non-standard sequence. The binding curve might also 
appear to be biphasic or suggestive of some complex binding mechanism 
(as opposed to being a simple sigmoid). With a relatively impure sample 
it is difficult to establish whether the origin of the complexity is indeed 
genuine or whether it is due to contaminating sequences present in the 
solution mixture. With regard to solution conditions and nucleic acids it 
is worth emphasizing that ITC is rarely if ever used as an isolated 
technique, when studying DNA. Generally ITC is used in conjunction 
with a series of experiments that typically involve circular dichroism 
(CD), UV/vis and fluorescence spectrophotometry.  
For meaningful experimental design and accurate data analysis it is 
clearly necessary to know the concentrations of nucleic acid (and ligand 
solutions) used in experiments.  In order to obtain meaningful data it is 
necessary to have a clear idea about the following parameters: (1) DNA 
concentration in the calorimeter cell, (2) ligand concentration in the ITC 
syringe, (3) total volume of the ligand solution to be injected, (4) volume 
of each serial injection, (5) time between injections, and (6) experimental 
temperature. To select values for each of these parameters it is useful to 
know something about the system under study, especially the 
approximate value for the binding constant and the stoichiometry. If, 
however, nothing is known a good starting point for small molecule–
nucleic acid interactions is to assume a binding constant of 10
5
 M
−1
 and a 
stoichiometry of 3:1 per ligand. The aim is to produce a sigmoidal 
binding curve, which can be fit with a model. Once the DNA 
concentration is established, the ligand concentration can be chosen by 
remembering that it is necessary to ensure that the total ligand 
concentration at the end of the titration should be twice that of the initial 
concentration of binding sites in the cell [107]. 
Due to the commercial availability of calorimeters sensitive enough to 
measure low energy interactions involved in a small amount of biological 
materials, ITC is being increasingly used to investigate the recognition of 
large biomolecules, like nucleic acids [107,95,108]. 
 
 
 
 
 
2.2. Circular Dichroism 
 
The optical activity of small molecules arises from their lack of 
symmetry, particularly, from the presence of asymmetric carbon atoms 
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and from the effect these atoms have on any nearby chromophores. On 
the other hand, the optical activity of the biological samples derives, 
essentially, from the conformation of the macromolecules in solution. 
There are at least four ways that an optically active sample can alter the 
properties of transmitted light: optical rotation, ellipticity, circular 
dichroism and circular birefringence. Circular Dichroism (CD) is the 
phenomenon that is recorded when an optical active sample interacts 
with the plane-polarised light, particularly, when the left circularly 
polarised light is absorbed in a different amount with respect to the right 
circularly polarised light. After passing through the sample each 
component is still circularly polarised, but the radii of the circle traced 
out by the electric vector of each are now different. When these two 
opposite circularly polarised light waves are combined together the result 
will be elliptically polarised light because the two components have 
different amplitude. Recording the CD at different wavelength allows 
obtain the CD spectrum that is strongly suggestive, for the biological 
samples, to the secondary structure content of the macromolecule (Figure 
2.3). 
 
 
 
 
 
Figure 2.3  Scheme of CD in which a difference in absorption is measured (adapted 
from ref. 109). 
 
 
 
So, any conformational changes in the structure of macromolecules could 
be assessed using circular dichroism. As a consequent, unfolding of 
biomolecules (such as proteins, nucleic acids, glycosides, etc.) is 
measured as a change in circular dichroism (CD) spectra, and serves to 
give a measure of the relative quantities of changes have been made in 
the components. According to the literature, for reporting the CD of a 
sample, mean residue ellipticity (degree cm
2
 dmol
−1
) and molar circular 
dichroism or delta epsilon (L mol
−1
cm
−1
) are common. Nucleotides are 
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the main building blocks, which have been used in asymmetric structure 
of nucleic acids (RNA/DNA). The chiral sugars of nucleosides have an 
intrinsic asymmetry and the interaction of the strong π→π* transitions of 
the chromophoric bases with the higher energy in the sugars yield a 
circular dichroism of low intensity. In fact, circular dichroism of nucleic 
acids is mainly dependent on the stacking geometry of the bases. The 
difference in CD between a nucleoside, adenosine (A), and a 
dinucleoside phosphate, adenylyl-3′-5′-adenosine (ApA), is illustrated in 
Figure 2.4 [110]. 
 
 
 
 
 
Figure 2.4  CD spectra of adenylyl-3′-5′-adenosine (ApA) compared with adenosine 
(A). For both molecules, the spectra are given per mole of nucleoside. The spectra are 
for aqueous solutions at pH 7 and room temperature (adapted from ref.109). 
 
 
 
CD of the dinucleoside phosphate per adenosine is about a factor of 10 
larger than the CD of adenosine. In adenosine, the CD depends on the 
interaction of adenine with its ribose and phosphate groups; whereas in 
the dinucleoside phosphate, the CD is mainly originated from the chiral 
adenine–adenine interaction. The combination of positive and negative 
extrema on either side of 260 nm is called an exciton band; there is 
another exciton band at 215 nm. The positive signs (long wavelength 
component positive, short wavelength component negative) of these two 
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bands indicate that the two adenines are forming a right-handed stack in 
ApA [110]. 
Today measurements of circular dichroismare widely used to quantify 
the association reactions between DNA and ligands. The association 
between the quadruplex structures and ligands can be studied by means 
of CD titrations. In particular, the saturation fraction (α) of the each 
quadruplex sample is measured, following the changes in molar 
ellipticity at caratheristicwavelenght upon ligand addition, using the 
following relationship: 
 
freebound
free
CDCD
CDCD



                                                                        
(eq. 1) 
 
where CD represents the CD signal at the wevelenght chosen at different 
molar ratios (ligand/quadruplex sample) investigated, freeCD represents 
the CD signal of the quadruplex sample alone and boundCD  is the CD 
signal of the saturated quadruplex samples. The resulting binding curves, 
obtained plotting the saturation fraction versus the molar ratio between 
the ligandand the quadruplex in solution, can be interpolated withan 
equation describing an equilibrium binding model. The interpolation 
analysis generally provides values for the stoichiometry (n) and binding 
constant (Kb). Two different models can be used in the interpolating 
procedure, the independent and equivalent-sites model and a cooperative-
sites model based on the Hill approach [111]. 
 
 
 
2.2.1. Determination of nucleic acid conformations 
 
The circular dichroism spectra of A-RNA, A-DNA, B-DNA and Z-DNA 
in the 200–320 nm range are shown in Figure 2.5. Both A-RNA and A-
DNA have spectra that are similar in shape. The A-RNA has a maximum 
near 260 nm, a minimum near 210 nm, and a small negative CD between 
290 and 300 nm. The A-DNA has a maximum at 270 nm, a minimum 
near 210 nm and zero CD at 300 nm and beyond. B-DNA has a 
conservative CD spectrum above 220 nm with approximately equal 
positive (275 nm) and negative (245 nm) components centered around 
260 nm [112]. 
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Figure 2.5  Circular dichroism spectra above 200 nm for right-handed A-RNA and A-
DNA, right-handed B-DNA, and left-handed Z- DNA (units are per M/cm/mol of 
nucleotide) (adapted from ref.113). 
 
 
 
The B-DNA maximum has less than one-half the magnitude of the A-
DNA maximum. Of course, the exact shapes and magnitudes of the CD 
spectra will depend on the base sequences, but the overall patterns will 
remain constant. The Z-DNA has a conservative spectrum above 240 nm 
with approximately equal negative (290 nm) and positive (260 nm) 
components centered around 280 nm. In summary, CD is most useful 
technique to compare DNA or RNA conformations and to detect changes 
when the solvent or temperature is changed [113], for this reason is 
extremely useful in conformational studies of G-quadruplex 
conformation in which the CD features are mainly influenced by stacking 
interactions between adjacent G-quartets [114]. The titration of 
quadruplexes with G4-ligands could induce change in the CD spectrum 
of quadruplexes and this change could be correlated to properties of the 
ligand under investigation. Although the topology of the folding of G4-
DNA strands is very complex and many types of quadruplexes have been 
reported, there are two basic types of CD spectra, which have been 
associated to a single specific difference in the features of the strand 
folding, the relative orientation of the strands, parallel (all strands have 
 35 
 
the same 5′ to 3′ orientation) or antiparallel. The spectra of “parallel” 
quadruplexes (a typical example is represented by the 
tetramolecularquadruplex formed by [d(TGGGGT)]4, in which four 
strands with all glycosyl bonds in anti conformation run parallel to each 
other) have a dominant positive band at 264 nm, and a negative peak at 
240 nm(Figure 2.6) [115,116]. On the contrary, the spectra of 
“antiparallel” quadruplexes (a typical example is represented by two 
folded-back strands of d[AG3(T2AG3)3] quadruplex in  Na
+
 solution, 
where guanines alternate syn and anti glycosyl conformation along each 
strand) have a negative band at 264 nm and positive band at 290 nm 
(Figure 2.6) [117]. 
Interestingly, the hybrid-type (3+1) human telomeric G-quadruplexes 
contain both the alternating and non-alternating glycosidic conformations 
for adjacent guanines on a G-strand (a typical example is represented by 
d[AG3(T2AG3)3] quadruplex in K
+
 solution), and thus exhibit a hybrid 
CD profile, with a positive peak around 290 nm and a smaller peak 
around 264 nm, and a smaller negative peak at 240 nm. The positive 
peak around 290 nm is likely due to the alternating guanine glycosidic 
conformations along G-strands between the top and middle G-tetrads in 
the hybrid-type telomeric G-quadruplexes, while the positive peak 
around 264 nm and the negative peak around 240 nm are likely due to the 
non-alternating guanine glycosidic conformations between the middle 
and bottom G-tetrads (Figure 2.6) [118]. 
 
 
 
 
Figure 2.6  CD spectra for the d[AG3(T2AG3)3] quadruplex in Na
+
 solution (red line) 
and  the K
+
 solution (green line); CD spectrum of the [d(TGGGGT)]4  quadruplex in the 
K
+
 solution (black line). 
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2.3. Steady-State Fluorescence 
 
Fluorescence spectroscopy has long been one of the most useful 
biophysical techniques available to scientists studying the structure and 
the function of biological macromolecules. Fluorescence is a 
spectroscopic method of analysis where the molecules are excited by 
irradiation at a certain wavelength and emit radiation of a different 
wavelength. The emission spectrum provides information for both 
qualitative and quantitative analysis. As shown in Figure 2.7, when light 
of an appropriate wavelength is absorbed by a molecule (excitation), the 
electronic state of the molecule changes from the ground state to one of 
many vibrational levels in one of the excited electronic states. The 
excited electronic state is usually the first excited singlet state, S1 (Figure 
2.7). Once the molecule is in this excited state, relaxation can occur via 
several processes. Fluorescence is one of these processes and results in 
the emission of light. 
 
 
 
 
 
Figure 2.7  Electronic transition energy level diagram. 
 
 
 
In order to study a molecule by fluorescence spectroscopy its needs to 
contain a fluorophore. Fluorophores are divided into two classes: 
intrinsic and extrinsic. Intrinsic fluorophores are those that occur 
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naturally. Extrinsic are those added to a sample. In proteins the dominant 
fluorophore is the indole group of tryptophan. The emission spectra of 
proteins are sensitive environment. Tryptophan residues are highly 
sensitive to the polarity of environment, which affects the energy levels 
of the first excited state with the result that the emission maximum can 
range from 330 nm in hydrophobic environment to 355 in water. DNA 
tipically doesn‟t display intrinsic fluorescence, DNA contains 
nitrogenous bases that look like fluorophores but is weakly or not 
fluorescent. However a wide variety of dyes spontaneously bind to DNA 
such as acridines. For this reason staining of cells  with dyes that bind to 
DNA is widely used to visualize and identify chromosomes. 
Measurement of fluorescence has been widely used to quantify the 
association reactions between DNA and fluorescent ligands. The 
observed fluorescence intensity is considered as the sum of the weighted 
contributions from free ligand and ligand bound to DNA: 
 
𝐹 = (1 − 𝛼𝑏)𝐹0 +  𝛼𝑏𝐹𝑏     ;       𝛼 =
𝐼𝜆−𝐼𝜆
𝑓𝑟𝑒𝑒
𝐼𝜆
𝑏𝑜𝑢𝑛𝑑 −𝐼
𝜆
𝑓𝑟𝑒𝑒                         (eq.2) 
 
where F is the observed fluorescence intensity at each titrant 
concentration, 𝐹0  and 𝐹𝑏  are the respective fluorescence intensities of the 
initial and final states of titration, and αb is fraction of bound ligand at 
each point of the titration and can be calculated, following the changes of 
fluorescence intensity at the wavelength of the maximum of emission. 𝐼𝜆  
represents fluorescence intensity at the wavelength of the maximum of 
emission at the different DNA concentrations investigated, 𝐼𝜆
𝑓𝑟𝑒𝑒
 
represents the fluorescence intensity of the drug alone and 𝐼𝜆
𝑏𝑜𝑢𝑛𝑑  is the 
fluorescence intensity signal of the saturated sample. 
Assuming 1:1 stoichiometry for the interaction, it can be shown that: 
 
[𝐿]0𝛼𝑏
2 − ([𝐿]0 + [𝑄] + 1/𝐾𝑏)𝛼𝑏 + [𝑄] =  0                                   (eq.3) 
 
where 𝐾𝑏  is the binding constant, [𝐿]0 is the total ligand concentration, 
and [𝑄] is the added DNA concentration. From combination of previous 
equations, it can be shown that: 
 
∆𝐹 =  
∆𝐹𝑚𝑎𝑥
2 𝐿 0
  (   𝐿 0 +  𝑄 + 1/𝐾𝑏) + 
− ( 𝐿 0 +  𝑄 + 1 𝐾𝐴)2 − 4 𝐿 0 𝑄                         (eq.4) 
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where 𝛥𝐹 =  𝐹 − 𝐹0 and 𝛥𝐹𝑚𝑎𝑥  =  𝐹𝑚𝑎𝑥 − 𝐹0 and F and F0 are the 
initial and subsequent fluorescence intensities of the ligand at wavelength 
of maximum emission, upon DNA addition [119]. 
Finally as I  already mentioned, the intrinsic fluorescence of most nucleic 
acids is too low for structural studies. Therefore, in recent studies a 
suitable fluorescent reporter group is incorporated to impart fluorescence 
to the polynucleotide structure. Highly fluorescent adenine analogue, 2-
aminopurine (2-AP), has been widely used as a probe for loop structures 
in quadruplex DNA. Its quantum yield is highly sensitive to 
environmental conditions and it can be used to probe the interaction of 
quadruplexes with small organic molecules. This purine can be 
incorporated in any quadruplex nucleic acid without changing the 
quadruplex conformation and only slightly affecting its stability. The 2-
AP fluorescence intensity tends to increase with solvent exposure and 
decrease with base stacking. The overall fluorescence of a quadruplex 
changes if a small molecule interacts in the proximity of 2-AP. The 2-AP 
modified human telomericquadruplexes have been used to monitor 
specific complex formation with porphyrin TMPyP4 [120]. 2-AP-
modified quadruplexes provided information about the stoichiometry and 
the binding mode of ligands. 
 
 
 
 
 
2.4. Docking and Molecular Dynamics 
 
Molecular modelling methods are nowadays routinely used to investigate 
structure, dynamics, surface properties and thermodynamics of 
biomolecular complexes. Docking and molecular dynamics  methods are 
used to predict binding modes and affinities of G-quadruplexes and small 
organic molecules. 
Docking is the process by which two molecules fit together in 3D space. 
This methodology is often used to predict protein-protein, protein-DNA 
(or RNA), and DNA (or RNA)-small molecule interactions. Predictive 
docking procedures start from the individually determined (unbound) 
structures of two molecules and they aim to predict the complex 
structure. All docking programs contain a scoring function to 
discriminate between near-native docked orientations and incorrect 
orientations, and a search algorithm that is designed to sample rapidly all 
possible docking orientations. Even though structural flexibility is mostly 
restricted to surface side chains [121], the innate flexibility renders 
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docking extremely difficult. The algorithm by Abagyan and colleagues 
[122,123] allows for surface side chain flexibility, however, such 
algorithms typically require hundreds of hours for each complex [122]. 
The alternative is to adopt the rigid-body approach, which samples only 
the six rotational/translational degrees of freedom, but uses target 
functions that are tolerant to some overlap of the two molecules being 
matched. Affinity docking module in INSIGHT II package 
(www.accelrys.com) was used. In docking, the interaction energy is 
computed by summing the energy contributions between all atoms of the 
two molecules. The contribution between atoms interacting with other 
atoms in the same molecule is ignored. The objective of a docking type 
calculation is to evaluate the interaction energies of many orientations of 
one molecule relative to the other, while searching for the orientations 
that result in low interaction energies. 
As proposed by Langridge [124] an energy grid approximating the larger 
of the two molecules can be precomputed. Since the interaction energy 
can now be approximated by calculating the energy between the atom of 
the moving molecule and the appropriate grid points, the docking can be 
done in real time.  
The construction of energy grids depends on the forcefield in use. 
The CFF (Cornell Force Field) forcefields use the nonbonded interaction 
potential 
𝐸𝑖𝑗 =  
𝐴𝑖𝑗
𝑅𝑖𝑗
9𝑖<𝑗
𝐵𝑖𝑗
𝑅𝑖𝑗
6                                                                                  (eq.5) 
 
where Aij and Bij are parameters with units of kcal mol
-1
 angstrom
9
 and 
kcal mol
-1
 angstrom
6
 respectively and Rij is the distance between atoms i 
and j in A.A completely equivalent representation is: 
 
𝐸𝑖𝑗 = 𝜀𝑖𝑗
∗  2  
𝑅𝑖𝑗
∗
𝑅𝑖𝑗
 
9
− 3  
𝑅𝑖𝑗
∗
𝑅𝑖𝑗
 
6
                                                            (eq.6) 
 
 
where 𝜀𝑖𝑗
∗  is the potential well depth in kcal mol
-1
 and 𝑅𝑖𝑗
∗  is the 
interatomic distance in angstroms at which the minimum occurs. The 
conversion between the two representations is straightforward: 
 
𝜀𝑖𝑗
∗ =   
4𝐵𝑖𝑗
3
27𝐴𝑖𝑗
2        ;    𝐴𝑖𝑗 = 2𝜀𝑖𝑗
∗ 𝑅𝑖𝑗
9  
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𝑅𝑖𝑗
∗ =  
3𝐴𝑖𝑗
2𝐵𝑖𝑗
 
1
3
;     𝐵𝑖𝑗 = 3𝜀𝑖𝑗
∗ 𝑅𝑖𝑗
6  
 
The docking module of INSIGHT II provides facilities for calculating the 
nonbond energy between two molecules using the methods described 
before. This calculation is performed using the Affinity program module 
in INSIGHT II. A key step before starting Affinity is to define a binding 
site subset. The binding site is defined to include important residues 
suggested by other studies. Several approaches for  non  bonds  are used: 
grid based approach, hydrogen bonding contacts, tethering atoms, and 
confining ligands. For the hydrogen bonding contacts feature, the most 
relevant subsets of atoms that are potential hydrogen bond partners are 
defined manually  by  picking them with the mouse. 
Then the general strategy involves a two-step process. First, use the 
Monte Carlo minimization approach to obtain reasonably placed ligands. 
The second phase of the docking involves a more refined approach. First, 
import the initial structures generated using Monte Carlo minimization. 
Then, use a more realistic nonbond like the Cell_Multipole  method. The 
starting structures have reasonable nonbond contacts, after a brief 
minimization (100 steps), a Simulated Annealing is perform over a 
reasonable number (50) of stages. These processes are repeated for all the 
relevant subsets involved in the hydrogen bonding contacts. The last step 
is to perform molecular dynamics. 
 
Molecular Dynamics (MD) is a computer simulation technique in which 
the time evolution of a set of interacting atoms is computed by 
integrating their equations of motion. Therefore, MD allows us to view 
how a molecular system evolves through time and to derive average 
properties of the system, given a simulation of sufficient length.  
The equations of motion can only be solved numerically for a multi-body 
problem. To calculate the dynamics of the system (the position of each 
atom as a function of time), Newton's classical equations of motion are 
solved for each atom given an empirical force field:  
 
𝐹𝑖  =  𝑚𝑖𝑎𝑖                                                                                          (eq.7) 
 
where 𝐹𝑖  is the force exerted on particle 𝑖, 𝑚𝑖  is the mass of particle 𝑖 and 
𝑎𝑖  is the acceleration of particle 𝑖. The force on each atom is the negative 
of the derivative of the potential energy (V) with respect to the position 
of the atom (𝑟1, 𝑟2, … , 𝑟𝑁): 
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𝐹𝑖 =  −
𝜕𝑉
𝜕𝑟𝑖
                                                                                           (eq.8) 
 
Once the coordinates of the atoms of a starting structure and their 
velocities are defined, the force acting on each atom can be calculated for 
each point in time  𝑡 +  𝑑𝑡 and a new set of coordinates can be 
generated. The repetition of this procedure generates a molecular 
trajectory corresponding to the time-dependent fluctuations of the atomic 
positions. The accuracy of the simulations is directly related to the 
potential energy function that is used to describe the interactions between 
particles. In MD a classical potential energy function is used that is 
defined as a function of the coordinates of each of the atoms. The 
potential energy function is separated into terms representing covalent 
interactions and non covalent interactions. The covalent interactions may 
be described by the following terms: 
 
𝑉𝑏𝑜𝑛𝑑 =  
1
2
𝑁𝑏
𝑖=1 𝑘𝑖
𝑏(𝑟𝑖 − 𝑟0.𝑖)
2                                                             (eq.9) 
 
𝑉𝑎𝑛𝑔𝑙𝑒 =  
1
2
𝑁𝜃
𝑖=1 𝑘𝑖
𝜃(𝜃𝑖 − 𝜃0.𝑖)
2                                                         (eq.10) 
 
𝑉𝑑𝑖𝑕𝑒𝑑𝑟𝑎𝑙 =  
1
2
𝑁Ф
𝑖=1 𝑘𝑖
Ф cos( 𝑛𝑖(Ф𝑖 − Ф0.𝑖))                                      (eq.10) 
 
𝑉𝑏𝑜𝑛𝑑 =  
1
2
𝑁𝜉
𝑖=1 𝑘𝑖
𝜉
(𝜉𝑖 − 𝜉0.𝑖)
2                                                           (eq.11) 
 
the equations correspond to two, three, four and four body interactions, 
respectively. Theseinteractions are represented by harmonic potentials 
for the bond lengths 𝑟𝑖 , for the bond angles 𝜃𝑖 , for the improper dihedral 
(out of the plane) angle 𝜉𝑖  and by a more complex potential for 
thedihedral angles Ф𝑖 . The non-covalent (non-bonded) interactions, 
which correspond to interactionsbetween particles separated by more 
than three covalent bonds, are usually described by Coulomb'slaw: 
 
𝑉𝐶𝑜𝑢𝑙𝑜𝑚𝑏 =  
1
4𝜋𝜀0𝜀𝑟
𝑖<𝑗
𝑞𝑖𝑞𝑗
𝑟𝑖𝑗
                                                               (eq.12) 
 
for the electrostatic interactions (for a pair of atoms carrying the partial 
charges qi and qj), and by aLennard-Jones potential: 
 
𝑉𝐿𝐽 =  
𝐴𝑖𝑗
𝑟𝑖𝑗
12𝑖<𝑗
𝐵𝑖𝑗
𝑟𝑖𝑗
6                                                                               (eq.13) 
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for the van der Waals interactions, where rij is the atomic distance 
between particles i and j. 
The force field parameters describe the strength of the interactions. For 
bonded interactions parameters are defined for bond stretching, bond 
bending and torsional rotation. Another set of parameters determines the 
strength of non-bonded electrostatic and van der Waals interactions. 
Electrostatic interactions are generally represented by point charges 
located at the center of the atom. It should be kept in mind, however, that 
MD is affected by several limitations. Firstly, MD is computationally 
very demanding and the computational load scales with the square of the 
system size. Simulation times are currently limited to hundreds of 
nanoseconds or a few microseconds at most. The phenomena that can be 
explored must occur with sufficient statistical significance within time 
scales that are encompassed by the computation. 
How the system evolves through time is specified by the force field and 
by an integration time step that determines where the atoms will be 
positioned at time𝑡 +  𝑑𝑡. MD requires the use of a very small time-step 
(1-2 fs) to achieve accurate results, because small time-steps limit the 
approximations that are introduced by the numerical integrator. This 
limits the overall scope of the simulated time and the computable 
properties. 
According to statistical thermodynamics, physical quantities are 
represented by averages over configurations belonging to a certain 
statistical ensemble. A trajectory obtained by molecular dynamics 
provides such an ensemble. Therefore, a measurement of a physical 
quantity by simulation is simply obtained as an arithmetic average of the 
various instantaneous values adopted by that quantity during the MD run. 
Statistical thermodynamics is the link between the microscopic 
ensembles and the macroscopic properties. In the limit of an exact force 
field and very long simulation times, one could expect the phase space to 
be fully sampled and in that limit the averaging process would yield 
exact thermodynamic properties. In practice, MD runs are always of 
finite length and one should exert caution when judging the sampling 
quality. An important constraint in deriving average properties is to 
extract configurations only from an ensemble at thermal equilibrium. 
Therefore, MD simulations start generally with an equilibration phase. 
Once equilibrium is reached, the simulation enters the production phase. 
The production run should belong enough to sample the property of 
interest with sufficient statistical significance. 
Molecular modeling and dynamics studies are very important for the 
recognition of a quadruplex motif, formed by human telomeric sequence. 
These studies enabled the improvement of a ligands, which possess a 
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moderate affinity for quadruplexes and no selectivity over double-
stranded DNA, by developing a derivative, which could represents a 
potent quadruplex binder. The first step of most computational studies 
involves manual docking of the ligand under investigation onto a 
quadruplex and it is imperative that one must carefully consider whether 
the chosen binding site is in agreement with known data about this 
ligand. 
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CHAPTER 3 TMPyP4 and human telomeric G-
quadruplexes 
 
 
 
 
 
3.1.  Interaction between TMPyP4 and four-
repeats human telomeric sequences 
 
Recently cationic porphyrins have emerged as a promising class of 
quadruplex-binding molecules with potential applications as anti-tumor 
therapeutic agents [125,126]. In particular, the cationic meso-tetrakis-(N-
methyl-4-pyridyl)-porphyrin (TMPyP4) has been the subject of extensive 
investigations since it can induce telomerase inhibition upon binding to 
telomeric DNA quadruplexes [127]. Interestingly, it was found that 
TMPyP4 can induce the formation of a DNA quadruplex from a single-
stranded oligonucleotide [128,129,130] The geometric features of the 
TMPyP4 ring (Figure 3.1) have been assumed to be appropriate to 
interact with the G-tetrads of quadruplex structures through π-π stacking 
interactions, however, the structure of TMPyP4-quadruplex complexes, 
as well as the binding stoichiometry, continue to be controversial. 
 
 
 
 
Figure 3.1 Chemical Structure of TMPyP4. 
 
 
 
Several different models of TMPyP4 binding to quadruplexes have been 
proposed on the basis of structural, spectroscopic, calorimetric or 
computational studies. Features of the various models include 
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intercalative binding of the drug between two adjacent G-tetrads and/or 
stacking with the external G-tetrads or with the loops of the quadruplexes 
[131,132,133,134,135,136]. This is further complicated by the intrinsic 
structural polymorphism of human telomeric quadruplex sequences. 
The binding stoichiometry of TMPyP4 to quadruplex structures is itself 
not fully established, especially for the quadruplexes from human 
telomeric sequences. For example, Hurley and co-workers determined by 
UV absorption spectroscopy a stoichiometric ratio of 2:1 for the binding 
of TMPyP4 to the 22-mer d[AGGG(TTAGGG)3] quadruplex in 100 mM 
Na
+
 buffer [127], while, more recently, Wei et al. using the same 
technique determined a 4:1 ratio for the same interaction in identical 
solution conditions [134]. Haq et al. have investigated by ITC the 
stoichiometry and thermodynamics for binding of TMPyP4 to the 
d[AGGG(TTAGGG)3] quadruplex structure in two different buffered 
solutions containing either K
+
 or Na
+
 at a fixed ionic strength (200 mM) 
[131]. The binding stoichiometry was the same for the two different 
solutions, in agreement with the 2:1 stoichiometry value previously 
determined for the human sequence by Hurley and co-workers [127]. 
However, the binding behavior in the Na
+
 buffer was found to be 
considerably different compared to the results obtained in K
+
 solution. 
Indeed, the interaction with d[AGGG(TTAGGG)3] in K
+
 was 
characterized by a single binding event, whereas the binding in Na
+
 
solution was characterized by an initial binding event requiring only low 
[TMPyP4]/[DNA] ratios to reach saturation, followed by a secondary 
process requiring a much higher ligand concentration for saturation. This 
data has shown that the interactions can be affected by the ionic 
environment used in the experiment, which may be one of the key factors 
determining the binding mode of TMPyP4 and the stoichiometry of the 
complexes, as also observed for other ligands [28]. Zhang et al. have 
recently characterized the binding of TMPyP4 to the human telomeric G-
quadruplex formed by d[TAGGG(TTAGGG)3T] for a range of K
+ 
concentrations [128]. They found that, in the presence of 0, 10 and 100 
mM K
+
, TMPyP4 forms complexes with a drug-quadruplex molar ratio 
of 5, 5 and 3, respectively. They also suggested that an increase in K
+
 
concentration would reduce the binding affinity of TMPyP4 and that it 
can transform the K
+
 induced hybrid-type quadruplex structure into an 
anti-parallel one. The latter finding was also suggested by Gaynutdinov 
et al. using 
125
I-radioprobing for a similar DNA sequence labeledwith
125
I 
[137]. Indeed, they showed that d[GGG(TTAGGG)3 
125
I-CT] is a 
mixture of two or more conformations in K
+
 solution, but adding 
TMPyP4 stabilizes a basket conformation. They also inferred that the 
same sequence adopts a basket conformation in the presence of Na
+
 and 
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the drug addition does not change the conformation of the quadruplex. 
This disagrees with a recent study by Gray et al. which shows that 
TMPyP4 addition promotes the conversion of d[AGGG(TTAGGG)3] 
from the basket to the hybrid form [78]. All the previous studies do not 
take into account binding of TMPyP4 to the parallel structure, possibly 
because it may only be present in dilute solution as a minor component. 
However, it has been shown that molecular crowding induces a structural 
transition of human telomeric G-quadruplexes to a parallel-stranded 
structure [63]. Moreover, in a very recent paper, Wei et al. studied the 
interaction of the d[AGGG(TTAGGG)3] sequence with TMPyP4, in both 
dilute solution and crowding condition [138]. They found that the 
crowding agent (PEG 200) induces the formation of a parallel-stranded 
quadruplex structure and two independent binding sites for the TMPyP4 
were found. It is therefore apparent that the binding mode of TMPyP4 to 
quadruplex molecules depends on the chemical features of the porphyrin, 
on the structure and composition of the host DNA, and on the 
environment used in the experiment. In this thesis is reported the use of 
Isothermal Titration Calorimetry  (ITC) and Circular Dichroism (CD) in 
a systematic study of the interaction between TMPyP4 and G-quadruplex 
molecules formed by four different sequences with 5‟- or 3‟-flanking 
bases  (Table 3.1), in both dilute solution and under molecular crowding 
conditions, to shed light on the recognition processes involving the 
human telomeric G-quadruplex structures and TMPyP4, and to evaluate 
the effect of the flanking bases addition. In order to investigate the 
selectivity of TMPyP4 for the quadruplex molecules relative to duplex, a 
study on the interaction between the drug and a duplex-forming 
oligonucleotide (Table 3.1), was also performed.  
All the oligonucleotide sequences used for this study were purchased 
from the Primm Company (Milan, Italy). Quadruplex and duplex 
samples have been prepared by dissolving the lyophilized compound in 
two different buffers, the first one containing 20 mM phosphate buffer 
with 70 mM KCl, 0.1 mM EDTA at pH 7.0, and the second one, used to 
reproduce the molecular crowding conditions, consisting of 20 mM 
phosphate buffer with 150 mM KCl, 0.1 mM EDTA, 40% (w/v) of PEG 
200 at pH 7.0. The concentration of the dissolved oligonucleotides was 
evaluated by UV measurement at 95 °C, using as molar extinction 
coefficient the value calculated at 260 nm, by the nearest-neighbor model 
(Table 3.1) [139]. The solutions of TMPyP4 (Sigma-Aldrich, USA) have 
been prepared in the same buffers used for the oligonucleotides, and the 
concentration has been estimated by UV spectroscopy using the reported 
extinction coefficient at 424 nm (226000 M
-1
cm
-1
). 
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Sequences 
ε260 nm
a 
M-1cm-1 
Nameb 
Major 
conform
ation in 
dilute 
solution 
Major 
conformation
c under 
molecular 
crowding 
condition 
TTAGGGTTAGGGTTAGGGTTAGGG 244600 wtTel24 hybrid-1 Parallel 
TAGGGTTAGGGTTAGGGTTAGGG 236500 wtTel23 hybrid-1 Parallel 
AGGGTTAGGGTTAGGGTTAGGGT 237000 wtTel23a hybrid-2 Parallel 
AGGGTTAGGGTTAGGGTTAGGGTT 245100 wtTel24b hybrid-2 Parallel 
CGCGAATTCGCG 110700 duplex duplex duplex 
 
Table 3.1 Thermodynamics of the TMPyP4 interaction  (
a
The error on the extinction 
coefficients is less than 4%,
b
Names reflect the convention used by Dai J. et al.[118], 
c
Evaluated from the CD spectrum). 
 
 
 
 
3.1.1. Results 
 
 
3.1.1.a. CD  experiments 
 
CD experiments were carried out to analyze the structural changes of the 
quadruplex samples upon TMPyP4 interaction. In the absence of 40% 
PEG 200, the sequences investigated show the typical CD spectrum of 
the hybrid conformation (Figure 3.2), with a maximum around 290 nm, a 
shoulder centered around 270 nm and a weak minimum around 240 nm 
[58]. The sequences wtTel23 and wtTel24 produce a stronger shoulder in 
the CD spectrum at 270 nm compared to the sequences wtTel23a and 
wtTel24b. The first two sequences have been shown to form in solution 
the hybrid-1 structure as major conformation, while the last two 
sequences form the hybrid-2 structure as major conformation [118]. 
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Figure 3.2  CD spectra of the quadruplexes in K
+
 solution. wtTel23 (A), wtTel24 (B), 
wtTel23a (C) and wtTel24b (D). Each panel shows spectra at increasing molar ratios of 
TMPyP4. The spectra, recorded at the higher TMPyP4 concentration, are 
representative of the final complexes deriving from the interaction between the 
quadruplex samples and the porphyrin molecules. 
 
 
 
The more intense signal at 270 nm in the spectra of the sequences 
wtTel23 and wtTel24 could be due to the presence of a significant 
amount of a parallel form in solution. Upon TMPyP4 addition, dramatic 
changes in the CD spectra are observed, suggesting that the TMPyP4 
molecule causes a conformational change in the quadruplex structures. In 
particular, the CD spectrum of each sample evolves toward the 
characteristic CD spectrum of an antiparallel quadruplex structure, with a 
maximum centered at 290 nm [118]. 
In order to obtain the stoichiometry of the complexes and to get a deeper 
understanding of the TMPyP4-quadruplex interaction, CD titration 
experiments were performed. CD spectra were collected at different 
TMPyP4/quadruplex molar ratios to calculate the saturation fractions 
(see above) of the quadruplex at different concentrations of TMPyP4. 
Binding curves for all the investigated systems were obtained by plotting 
the saturation fractions as a function of the molar ratio (Figure 3.3). 
Intriguingly the sequences wtTel23 and wtTel24, forming the hybrid-1 
structure as major conformation in solution [118], show sigmoid-shaped 
binding curve centered on a stoichiometry of four (Figure 3.3, panels A 
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and B). On the other hand the sequences wtTel23a and wtTel24b, 
forming the hybrid-2 structure as major conformation, show a hyperbolic 
binding curve, suggesting a stoichiometry of four bound TMPyP4 
molecules (Figure 3.3, panels C and D). The different shape of the 
binding curves suggests a different mechanism of interaction of TMPyP4 
with the quadruplexes obtained with the sequences wtTel23 and wtTel24 
compared to the ones formed with the sequences wtTel23a and 
wtTel24b. Particularly, a sigmoid-shaped rather than a hyperbolic 
binding curve indicates a cooperative mechanism.  
 
 
 
 
 
Figure 3.3  CD titration experiments on the interaction between TMPyP4 and the 
quadruplex structures formed by the sequences wtTel23 (A), wtTel24 (B), wtTel23a (C) 
and wtTel24b (D). The open circles represent the experimental data obtained following 
the change of the CD signal at 290 nm, upon TMPyP4 addition. The graph line 
represents the theoretical curve obtained on the basis of a cooperative-sites model (A, 
B) or equivalent-sites model (C, D). 
 
 
 
On this basis an interpolation analysis has been carried out using two 
different models for the two classes of binding curves. The experimental 
binding curves of the sequences wtTel23 and wtTel24 are well modelled 
to an equation describing cooperative-sites, while the binding curves 
obtained with the sequences wtTel23a and wtTel24b have been modelled 
to an equation assuming equivalent-sites. The results of the interpolation 
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analysis clearly indicate that all of these quadruplexes are able to bind up 
to four TMPyP4 molecules; intriguingly, the sequences wtTel23a and 
wtTel24b possess a ten-fold higher affinity (Kb = 1.4 x 10
6
 M
-1
 for both 
systems) for TMPyP4 compared to the sequences wtTel23 and wtTel24 
(Kb = 1.0 x10
5
 M
-1
 and Kb = 1.5 x 10
5
 M
-1
, respectively). It is worth 
noting that the Kb values obtained are indicative of the global events and 
they take into account both binding and conformational change. 
In the presence of 40% PEG 200, the CD spectra of the quadruplex-
forming oligonucleotides show dramatic differences compared to the 
ones previously observed (Figure 3.4). 
 
 
 
 
Figure 3.4  CD spectra of the quadruplexes under molecular crowding condition. 
wtTel23 (A), wtTel24(B), wtTel23a (C) and wtTel24b (D). Each panel shows the 
spectrum of the quadruplex structure in absence of TMPyP4 and in presence of a high 
molar ratio of TMPyP4. 
 
 
 
Interestingly, all the spectra show a well-defined maximum around 268 
nm and a minimum at 241 nm, suggesting that a higher fraction of the 
oligonucleotides fold in a parallel quadruplex structure. A shoulder, 
centered on 290 nm, is also present and its intensity becomes higher as 
follows: wtTel23 ≈ wtTel24 < wtTel23a < wtTel24b, those results are 
consistent with the possible presence of additional minor conformations. 
Interestingly, under molecular crowding condition, the addition of 
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TMPyP4 does not cause dramatic changes in the CD spectra. The global 
shape of the spectra is conserved and the molar ellipticity becomes 
slightly higher, since,  probably, the TMPyP4 interaction does not cause 
a conformational change of the quadruplex structure under these 
conditions. Since the changes in the CD signals, upon TMPyP4 addition, 
are small they did not allow to obtain a binding curve as was possible in 
the absence of 40% PEG 200. 
The spectroscopic characterization of the TMPyP4 interaction was also 
carried out for the duplex, in both dilute solution and under molecular 
crowding conditions. The CD spectra of the duplex-forming 
oligonucleotide show the same profile in both conditions (Figure 3.5), 
suggesting that the duplex structure is not affected by the presence of the 
molecular crowding agent. The addition of TMPyP4 does not change the 
shape of the spectra, suggesting that the TMPyP4 interaction does not 
promote any conformational change in the duplex DNA structure. 
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Figure 3.5  CD spectra of the duplex in dilute solution (on the right) and under 
molecular crowding condition (on the left), in absence and in presence of TMPyP4. 
 
 
 
3.1.1.b. ITC experiments 
 
To better address the differences between the binding properties shown 
by the studied sequences, both in dilute solution and under molecular 
crowding condition, a calorimetric analysis of the porphyrin interaction 
has been carried out by means of isothermal titration experiments. In 
dilute solution, the results collected for the two classes of sequences, 
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forming the hybrid-1 or hybrid-2 structure, are quite different. The 
binding curves related to the sequence wtTel23 and wtTel24 show more 
complicated profiles compared to the sequences wtTel23a and wtTel24b. 
All the normalized heat binding curves have biphasic profiles, with two 
separate binding events centered on two different stoichiometries (Figure 
3.6). In the first event, one molecule of TMPyP4 interacts with the 
quadruplex structure followed by the simultaneous binding of three more 
TMPyP4 molecules, allowing the formation of a final complex composed 
of one molecule of quadruplex with four molecules of TMPyP4. The 
calorimetric binding curves of the sequences forming the hybrid-1 
structure have been analyzed assuming that the two binding events are 
independent of each other. On the basis of the previous assumption, the 
first event has been interpolated with a simple independent and 
equivalent-sites model (Figure 3.6 panels A and B, black line graph) 
whereas the second event has been analyzed with a cooperative-sites 
model (Figure 3.6 panels A and B, red line graph). 
This analysis reveals that the first event (Kb = 2 x 10
6
 M
-1
 for both 
sequences) is about ten-fold stronger than the second one (Kb = 5 x 10
5
 
M
-1
 for both sequences). The binding curves obtained for the sequences 
wtTel23a and wtTel24b (Figure 3.6, panels C and D) are well fitted using 
a multiple-sites model and the analysis suggests that the first binding 
event (Kb = 5 x 10
8
 M
-1
 for wtTel23a and wtTel24b) is about 100-fold 
stronger than the second one (Kb = 4 x 10
6
 M
-1
and Kb = 2 x 10
6
 M
-1
 for 
wtTel23a and wtTel24b, respectively). The high quality of the 
calorimetric measurements allowed to obtain a complete thermodynamic 
characterization for all the investigated systems (Table 3.2). 
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Figure 3.6  Normalized heat of interaction between TMPyP4 and the quadruplex 
structures formed by the sequences wtTel23 (A), wtTel24 (B), wtTel23a (C) and 
wtTel24b (D). The open circles represent the experimental data obtained by integrating 
the raw data and subtracting the heat of ligand dilution into the buffer. The lines 
represent the best fit obtained by a non-linear least-squares procedure based on three 
different interpolating models: independent sites (black line, panels A and B), 
cooperative sites (red line, panels A and B) and multiple sites (red line, panels C and 
D). Each panel shows the thermodynamic signature of the corresponding interaction. 
The enthalpic contribution (∆H°) is shown in green, the entropic one (-T∆S°) in red and 
the Gibbs energy change (∆G°298K) in blue. 
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In dilute solution 
 
First event Second Event 
n1 
Kb 
(M
−1
) 
ΔH° 
(kJ mol
−1
) 
−TΔS° 
(kJ mol
−1
) 
ΔG°298K 
(kJ mol
−1
) 
n2 
Kb 
(M
−1
) 
ΔH° 
(kJ mol
−1
) 
−TΔS° 
(kJ mol
−1
) 
ΔG°298K 
(kJ mol
−1
) 
wtTel23 1.1 2 x 10
6
 -5.0 -30.9 -35.9 3.0 5 x 10
5
 -2.0 -30.5 -32.5 
wtTel24 0.9 2 x 10
6
 -9.4 -26.5 -35.9 3.0 5 x 10
5
 -6.0 -26.5 -32.5 
wtTel23a 1.0 5 x 10
8
 -5.2 -44.4 -49.6 2.9 4 x 10
6
 -2.2 -35.4 -37.7 
wtTel24b 0.9 5 x 10
8
 -7.9 -41.7 -49.6 2.9 2 x 10
6
 -3.3 -32.6 -35.9 
duplex 1.0 8 x 10
5
 -54.0 20.3 -33.7      
Under molecular crowding conditions 
wtTel23 1.0 3 x 10
8
 -30.7 -17.9 -48.6 2.9 1 x 10
7
 -5.0 -35.7 -40.7 
wtTel24 0.9 2 x 10
8
 -26.0 -21.4 -47.4 2.9 6 x 10
6
 -6.9 -32.0 -38.9 
wtTel23a 0.9 2 x 10
8
 -65.2 17.8 -47.4 2.9 4 x 10
6
 -12.3 -25.8 -38.1 
wtTel24b 1.0 1 x 10
8
 -102.5 55.6 -46.9 3.0 7 x 10
6
 -17.4 -21.8 -39.2 
duplex 1.0 6 x 10
5
 -54.0 21.0 -33.0      
 
Table 3.2  Thermodynamics of the TMPyP4 interaction (The experimental error for each thermodynamic property is < 5%. n1 and n2 are 
referred to the number of TMPyP4 molecules interacting in each binding event; the final stoichiometry of the complexes is n tot = n1 + n2). 
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The thermodynamic signature of the two binding events (Figure 
3.6, inserted bar-graphs) for each quadruplex sample suggests that 
the TMPyP4 interaction is entropically driven and the small 
enthalpic contribution (∆H°) acts synergistically with the larger 
entropic one (-T∆S°). The thermodynamic characterization reveals 
some interesting features about the binding process. Particularly, 
the negative entropic contribution suggests that the TMPyP4 
interaction produces a more relaxed structure with respect to the 
unbound quadruplex. Moreover, the small enthalpic contribution 
clearly indicates that the driving force of the binding process is not 
represented by the formation of new interactions between the 
binder and the target molecules, but it is principally due to the 
relaxation of the entire structure upon TMPyP4 interaction. 
Under molecular crowding conditions, all the sequences show 
equivalent behaviour, producing similar binding profiles (Figure 
3.7). Particularly, all the binding curves are biphasic revealing two 
well-defined events centered on the stoichiometry of one and four 
bound TMPyP4 molecules.  
The interpolation procedure of the experimental data has been 
carried out with a multiple-sites model and the analysis suggests 
that the first binding event is about 100-fold stronger than the 
second one (Table 3.2). The thermodynamic characterization of the 
binding events (Table 3.2), summarized in the thermodynamic 
signature reported in Figure 3.7 (inserted bar-graphs), reveals that 
the two binding events are driven by different thermodynamic 
contributions. The first binding event is the strongest one and is 
enthalpically driven, while the second event, the weaker one, is 
entropically driven; those data clearly suggest that the two 
consecutive binding events occur by distinct mechanisms and 
probably they involve different regions of the quadruplex structure. 
In the first event the formation of new interactions is the key 
feature of the binding, and the opposing entropic contribution 
suggests that the resulting complex is more rigid with respect to the 
free quadruplex. On the other hand, the second binding event is 
centered on higher molar ratios of TMPyP4 and is entropically 
driven, suggesting that the resulting final complex is a more 
relaxed structure. 
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Figure 3.7  Normalized heat of interaction between TMPyP4 and the quadruplex 
structures formed by the sequences wtTel23 (A), wtTel24 (B), wtTel23a (C) and 
wtTel24b (D) under molecular crowding condition. The open circles represent 
the experimental data obtained by integrating the raw data and subtracting the 
heat of ligand dilution into the buffer. The lines represent the best fit obtained by 
a non-linear least-squares procedure based on a multiple sites binding model 
(red line). Each panel shows the thermodynamic signature of the corresponding 
interaction. The enthalpic contribution (∆H°) is shown in green, the entropic one 
(-T∆S°) in red and the Gibbs energy change (∆G°298K) in blue. 
 
 
 
The ITC measurements have also been carried out on the duplex in 
both solution conditions (Figure 3.8). In both cases, the results of 
the calorimetric titrations show an exothermic interaction (ΔH° = -
54 kJ mol
-1
) with a stoichiometry of one molecule of TMPyP4 per 
duplex and similar binding constants (Kb = 8 x 10
5
 M
-1
 and Kb = 6 x 
10
5
 M
-1
 in dilute solution and under molecular crowding condition, 
respectively). 
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Figure 3.8  Normalized heat of interaction between TMPyP4 and duplex 
molecule in both A) dilute solution and B) under molecular crowding condition. 
The filled square represent the experimental data and the red line represents the 
best fit obtained by non linear least square based on the independent site model. 
 
 
 
3.1.2. Discussion and Conclusions 
 
Four different human telomeric truncated sequences have been 
chosen to characterize the interaction between the human 
quadruplex structures and TMPyP4, in dilute solution and under 
molecular crowding condition. All the oligonucleotide molecules 
contain the core sequence 5'-AGGG(TTAGGG)3-3', and are able to 
fold into a quadruplex structure, with differing numbers of flanking 
thymines either at the 5' or 3' terminal or at both termini. These 
oligonucleotides (Table 3.1) have been previously studied from a 
structural point of view and in dilute K
+
 solution they form a 
mixture of at least, two conformations of intramolecular 
quadruplexes: the hybrid-1 and the hybrid-2 conformations [60,61]. 
The major conformation appears to be flanking nucleotide-
dependent and intriguingly, the presence of thymines at the 3‟ end 
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region seems to drive their structures toward hybrid-2 structure 
formation [118]. The differing features between those structures are 
mainly due to the different loop arrangement and to the presence of 
two different cap-regions in the two structures. Particularly, the 
hybrid-1 conformation comprises G-quadruplex scaffold of three 
G-tetrad planes, with three interconnecting loops and a cap 
containing three hydrogen-bounded adenines that stacks on the 5‟ 
terminal G-tetrad plane [56]. This structure could contain an 
additional flanking nucleotide tail at the 5‟ terminal region, 
depending on the presence of thymines at the beginning of the 
sequences. The hybrid-2 structure is quite similar but the loop 
arrangement is different and possesses a distinct cap with two 
thymines and one hydrogen-bonded adenine that stacks on the 3‟ 
terminal G-tetrad plane of the quadruplex scaffold [56]. This 
structure, in contrast to the hybrid-1 one, could possess up to two 
flanking nucleotide tails at the terminal regions, depending on 
sequence. The stability of the two structures is due to a 
combination of the presence of the basic structural features 
(quadruplex scaffold, loops and cap region) of each structure, plus 
the effect coming from the presence of possible flanking nucleotide 
tails. Since the adenine cap has greater stability compared to the 
analogous one found in the hybrid-2 structure, the hybrid-1 fold is 
more stable than the hybrid-2 one. The results of several 
biophysical studies do not exclude the presence of additional 
structures in solution [137,118]. Indeed, another possible folding of 
these oligonucleotides seems to be represented by the basket-type 
conformation that has been recently found as the major structure in 
K
+
 solution for the sequence d[(GGGTTA)3GGGT] [57], which 
may be more stable than either hybrid forms. This conformation, 
termed Form-3, is an antiparallel structure, possessing only two G-
tetrad planes, with novel interconnecting loops. The existence of 
the Form-3 conformation shows that the polymorphism of the 
human telomeric DNA sequences in dilute solution is yet more 
complex than was previously assumed, with the implication that it 
may be yet more challenging to understand the basic principles 
governing drug-quadruplex interaction processes. On the other 
hand, under molecular crowding condition the major conformation 
seems to be represented by the parallel structure and to date, this 
topology is the only one clearly identified under this type of 
condition, which may be more representative of a cellular 
environment. It seems that the polymorphism of quadruplex formed 
by telomeric DNA sequences is diminished under molecular 
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crowding condition and the parallel structure is the favoured one, 
probably due to its particular structural features that enable optimal 
adaptation to that environment, especially the large and accessible 
G-tetrad surface areas at both 5‟ and 3‟ ends. 
The combination of  spectroscopic and calorimetric results 
obtained both in dilute solution and under molecular crowding 
condition, enables to shed light on the recognition processes 
between the quadruplex structures formed by the human sequences 
and TMPyP4. The CD and ITC experiments indicate that, in 
agreement with the previously reported study of Wei et al. [134], 
the final stoichiometry of the complexes is four. The spectroscopic 
results in dilute solution indicate that the porphyrin molecules, 
interacting with the hybrid structures, promote a major 
conformational rearrangement converting the hybrid structures into 
a basket one. Since the CD spectra of the complexes between the 
sequences investigated here and TMPyP4, in solution, share 
similarities with the CD spectrum of the recently studied Form-3 
structure, it is plausible to speculate that Form-3 could be involved 
in the TMPyP4 interaction, though yet other forms cannot be 
excluded. Probably, the Form-3 conformation possesses the 
structural features to efficiently bind up to four molecules of 
TMPyP4. The Form-3 structure differs from the basket 
conformation found in Na
+
 solution not only in its smaller number 
of G-tetrad planes but also in the presence of the distinct loop 
sequences, GTTA and GTTAG rather than the classical telomeric 
DNA loop sequence TTA. These longer loop sequences; together 
with the reduced number of G-tetrad planes could make the global 
structure more relaxed. The greater flexibility of Form-3 with 
respect to the hybrid structures could be the key feature that 
explains its affinity for TMPyP4 molecules. On the other hand, the 
calorimetric analysis in dilute solution reveals that the four 
molecules of TMPyP4 do not simultaneously bind the hybrid 
structures, but the interaction is sequential and composed of two 
distinct binding events. In the first event one molecule of TMPyP4 
interacts with the quadruplex structure and after that, in the second 
event, three other molecules interact with the structure. Both events 
cooperate to promote a conformational change from the hybrid 
structures to the basket-type structure, according to the 
spectroscopic derived binding curves. The calorimetric results 
show that the global Gibbs energy change for the binding of 
TMPyP4 to the hybrid-1 structure is lower (about -68 kJ mol
-1
) 
than that for the hybrid-2 structure (about -86 kJ mol
-1
) and this 
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difference could derive from the higher stability of the hybrid-1 
structure due to its adenine cap [56]. It is plausible that the 
interaction of TMPyP4 molecules with the 5‟ terminal G-tetrad 
plane of the hybrid-1 structure destabilizes the adenine cap. This 
could be a releasing event allowing the hybrid structures to evolve 
toward the Form-3 conformation, producing the final complex. The 
disruption of the adenine cap could explain the cooperative profiles 
of the binding curves obtained, for the hybrid-1 structures, with 
both circular dichroism and isothermal titration calorimetry. The 
hybrid-2 conformation does not possess a structured cap on the 5‟ 
terminal G-tetrad plane, moreover, that plane is partially solvent 
exposed because of the absence of the flanking nucleotide tail, 
making this structural region an attractive target for binding 
molecules. Probably, the first binding event revealed by ITC could 
be related to a TMPyP4 molecule that binds to the hybrid structures 
via stacking interactions on the 5‟ terminal G-tetrad plane, which 
would be consistent with the lower binding constant values 
obtained for the hybrid-1 structures with respect to those obtained 
for the hybrid-2 structures. In particular, the lower values found for 
the hybrid-1 structures take into account the disruption of the 
adenine cap. The second binding event found by ITC shows the 
same thermodynamic properties for both hybrid-1 and hybrid-2 
structures, suggesting that in both cases the three TMPyP4 
molecules interact with similar structural elements. Probably the 
three porphyrin molecules involved in the second binding event 
interact with the quadruplex structure in the final step of the 
conformational change, when the basket-type structure is almost 
reached. It is plausible that the three interconnecting loops of the 
Form-3 structure could be individually the targets for binding the 
final three TMPyP4 molecules. Comparing the previous results 
with the ones obtained for the duplex in dilute solution, we found 
that the TMPyP4 does not have significantly higher affinity for the 
hybrid-1 structures with respect to the duplex. On the other hand, 
just considering the first binding event, the affinity of TMPyP4 for 
the hybrid-2 structures is about 100-fold higher than the one 
measured for duplex. This intriguing result has not been observed 
to date, probably because the majority of the previous studies were 
focused on the hybrid-1 forming sequences. 
Binding of TMPyP4 to human telomeric quadruplexes is 
qualitatively different in conditions where molecular crowding 
takes place. Our spectroscopic analysis reveals that the parallel 
structure is the most populated conformation in this state, and that 
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the interaction with the TMPyP4 does not promote any 
conformational change. This result suggests that the parallel 
structure possesses the features to bind and allocate up to four 
porphyrin molecules, in general accord with features found in the 
crystal structure of a bimolecular telomeric quadruplex-TMPyP4 
complex [135]. The calorimetric analysis reported here does not 
reveal significant differences between the four sequences; in 
particular the global Gibbs energy change for the binding of each 
sequence to TMPyP4 are similar and average around -86 kJ mol
-1
. 
The thermodynamic analysis suggests that the molecular 
mechanism of the interaction with TMPyP4 is the same for all the 
sequences, suggesting that the conformations of the complexes are 
structurally homogeneous. The thermodynamic signature of the 
first binding event is typical of an end stacking-mode interaction, in 
which the enthalpic contribution is higher than the entropic one, 
and one of the two G-tetrad terminal planes could be the target 
region involved in this first event, as shown in the NMR structure 
of a non-telomeric (c-myc) quadruplex with bound TMPyP4 [140]. 
A detailed examination of this structure shows that, contrary to 
expectation, the porphyrin core does not actually stack onto a G-
tetrad, since its dimensions preclude this from occurring [94]. 
Instead, the edges of the out-of-plane pyridyl groups are in contact 
with the G-tetrad plane: an analogous arrangement is likely with 
telomeric quadruplexes. The second binding event is entropically 
driven, suggesting that it causes a relaxation of those regions of the 
quadruplex structure involved in the interaction. Moreover this 
event occurs with three different molecules of TMPyP4 that 
simultaneously bind to the quadruplex structure. These three 
similar regions of the quadruplex structure could be represented by 
the three interconnecting loops, with interactions as found in the 
crystal structure of the TMPyP4-quadruplex complex [135]. 
A study of the interaction between the quadruplex structure from 
the sequence d[AGGG(TTAGGG)3] and TMPyP4, reported a 
global stoichiometry of 1.5 molecules of porphyrin per quadruplex 
structure under molecular crowding condition [138]. The formation 
of a sandwich-like complex was proposed on the basis of their 
results, in which one TMPyP4 molecule is placed between the 
external planes of two distinct quadruplexes and other two 
TMPyP4molecules are bound to the grooves of the two 
quadruplexes. We also found a first stronger binding event 
followed by a weaker one, in agreement with this study but our 
results do not suggest the formation of sandwich-like complexes. 
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This could possibly be due to the presence of flanking bases 
situated at the 3‟ or 5‟ terminal region. These are flexible structural 
elements that span the external planes and could prevent dimer 
aggregation between two quadruplex structures via end stacking 
interactions. From the comparison of these results, can assessed 
that under molecular crowding condition, the porphyrin is able to 
bind the quadruplex structure with higher affinity compared to the 
duplex DNA structure. This finding is completely unexpected and 
suggests that the potential biological applications of TMPyP4 may 
be more selective than has been previously assumed. 
The overall picture, suggests that TMPyP4 molecules could bind to 
the truncated human quadruplex sequences, both in dilute solution 
and under molecular crowding, via two distinct stacking-mode 
interactions: with the external G-tetrad planes and with the bases of 
the interconnecting loops between the G-tetrad planes. The two 
TMPyP4-quadruplex molecular structures available to date each 
show just one of the two possible binding-modes [135,140]. The 
nature of the complexes reported in this study could involve both 
mode of interaction, and they could be helpful in future chemical 
optimization to enhance the affinity of porphyrin-type molecules 
for telomeric quadruplex structures. 
 
 
 
 
 
3.2. Interaction between TMPyP4 and eight-repeats 
human telomeric sequence 
 
In this paragraph have been discussed the binding proprieties of the 
multimeric structure formed by the sequence (TTAGGG)8TT with 
cationic TMPyP4 (Figure 3.1) and compared with the quadruplex 
forming sequence (AG3TT)4 (wtTel24b, Table 3.1), through a 
combination of spectroscopic (CD, UV and fluorescence) and 
calorimetric techniques (ITC). The (TTAGGG)8TT telomeric 
sequence consists of two consecutive mixed-type quadruplexes, 
one having the Hybrid-1 conformation and the other having the 
Hybrid-2 conformation, this model has been validated 
experimentally [64]. TMPyP4 is a good starting drug to explore the 
difference in the binding properties of multimers in comparison 
with individual quadruplexes as its interactions with individual 
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quadruplex structures have been extensively studied. The changes 
of the TMPyP4 spectroscopic properties (fluorescence, induced 
CD, UV spectrum) upon G-quadruplex binding are known to be 
large making it particularly suitable as experimental probe to 
explore the binding properties of a new G-quadruplex structure. 
Further, TMPyP4 has a high solubility allowing to reach the high 
[drug]/[DNA] ratio required in the ITC titrations to explore the 
binding of longer telomeric sequences.  
The (AGGGTT)4, (TTAGGG)8TT oligonucleotide sequences were 
studied in a buffer solution containing 20 mM phosphate, 0.1 mM 
EDTA, 100 mM KCl. The concentration of oligonucleotides was 
determined by UV adsorption measurements at 90 °C using molar 
extinction coefficient values ε(260 nm) of 245100, 505600 M−1 
cm
−1
 for (AGGGTT)4, (TTAGGG)8TT, respectively [139]. 
TMPyP4 solutions have been prepared in the same buffer used for 
the oligonucleotides, and the concentrations have been estimated 
by UV spectroscopy using the reported molar extinction coefficient 
value of ε (424 nm) = 226000 M−1 cm−1 [141]. 
 
 
 
 
3.2.1. Results 
 
 
3.2.1.a. ITC experiments 
 
The binding of TMPyP4 to the (TTAGGG)8TT sequence was 
characterized by means of isothermal titration experiments (ITC). 
In each titration, volumes of 5–10 μL of a solution containing 
TMPyP4 at a concentration of 160–280 μM, were injected into a 
DNA solution (10–20 μM) in the same buffer, using a computer-
controlled 250 μL microsyringe. 
The ITC binding curve obtained from the integration of the heat 
data has a sigmoidal behaviour and was fitted with an independent 
and equivalent-sites model (Figure 3.9), the best–fit parameters are: 
n=4.0,    Kb = 2.4x10
6  ±0.1 M−1, ΔbH
0=−6.2±0.3kJmol-1, 
−TΔbS
0 = −30.2 ± 0.3 kJmol−1 and ΔbG298K
0 = −36.4 ±
0.2 kJmol−1 (n is referred to the number of ligand molecules 
interacting in each binding event). In insets of Figure 3.9 the free-
energy changes for the binding processes were parsed into the 
respective enthalpic and entropic contributions. Both the enthalpic 
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and the entropic terms are favourable to the binding, the largest 
contribution was the entropic one. The negative enthalpic 
contribution indicate the formation of new interactions upon 
binding whereas the positive entropic contribution could be due to 
a release of water molecules or/and a relaxation of the structure 
[142,143]. 
 
 
 
 
 
Figure 3.9  Normalized heat of interaction between TMPyP4 with the structure 
formed by the (TTAGGG)8TT sequence. The solid circles are the experimental 
data obtained by integrating the raw data and subtracting the heat of ligand 
dilution into the buffer. The red line represents the best fit obtained with the 
independent-sites model. The inset shows the thermodynamic signature of the 
corresponding interaction. The enthalpic contribution (ΔH0) is shown in green, 
the entropic one (-TΔS0) in red and the Gibbs energy change (ΔG0298K) in blue. 
 
 
 
As previously described, four TMPyP4 molecules bind the 
(AG3TT)4  quadruplex (wtTel24b in dilute solution, Table 3.2) but 
in two separate events: in the first event, one TMPyP4 molecule 
binds the quadruplex with a Kb of 5×10
8
M
−1
, in the second event, 
other three molecules bind the quadruplex with a Kb of 2×10
6
 M
−1
. 
Instead the thermodynamic parameters (Kb, ΔbH
0
 and -TΔbS
0
) for 
the binding of TMPyP4 to the (TTAGGG)8TT structure are similar 
to the ones reported for the second binding event in the (AG3TT)4 
quadruplex (Table 3.2) but greatly differ (especially the Kb and the 
-TΔS term) from the parameters characterizing the first binding 
event. The total stoichiometry (sum of the two binding events) of 
4:1 reported for the (AG3TT)4  quadruplex is the same of the 
stoichiometry observed for the two-quadruplexes forming sequence 
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(TTAGGG)8TT. This result reveals a decrease of the number of 
binding sites for each quadruplex unit in the (TTAGGG)8TT 
structure (two binding sites per quadruplex unit) in comparison 
with the (AG3TT)4  quadruplex (four binding sites per quadruplex). 
 
 
 
3.2.1.b. CD experiments 
 
To get more information on the conformation of the multimer–drug 
complexes, CD measurements were performed. Figure 3.10A 
shows the changes in the CD spectrum of (TTAGGG)8TT on 
increasing the amount of TMPyP4.  
Cell with 0.1 and 1.0 cm path length and oligonucleotide 
concentrations in the range 2–40 μM were used to record CD 
spectra between 220 and 320 nm.  
The CD spectrum of the (TTAGGG)8TT in absence of ligand 
shows the characteristic shape of a mixed-type (Hybrid-1 and 
Hybrid-2) G-quadruplex structures and its intensity is consistent 
with the formation of two-quadruplex units [75]. There are little 
changes of the (TTAGGG)8TT spectrum on increasing the 
TMPyP4 concentration indicating that the binding of the ligand 
does not cause drastic conformational changes in the overall 
multimer structure (Figure 3.10A). Figure 3.10B shows the induced 
CD of the TMPyP4 on increasing (TTAGGG)8TT concentration.  
Then Induced CD titrations were carried out by stepwise addition 
of DNA solutions to a cell containing drug solution. The 
concentration of TMPyP4 was 40 μM. The DNA concentration was 
varied in the range 0–60 μM and the spectra were acquired in the 
wavelength range 300-600. 
ICD of TMPyP4 has a complex behaviour on changing 
[TMPyP4]/[DNA] ratio, particularly, it has a negative value in the 
440 nm region for a [TMPyP4]/[DNA] binding ratio <3.5 but it 
shows both positive and negative peaks for a binding ratio >3.5. 
Negative ICD in the Soret region of TMPyP4 is consistent with an 
end-stacking binding mode whereas positive ICD bands are 
diagnostic of an external binding mode [144,145,146]. This result 
suggests that two different binding modes are present that 
contribute to the ICD signal: an end-stacking mode at low 
[drug]/[DNA] ratio with a negative ICD and an external binding at 
higher binding ratio that gives a positive contribution to the total 
ICD signal. 
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Figure 3.10  (A) CD spectra of (TTAGGG)8TT (2 μM) on increasing TMPyP4 
concentration in the range 0–16 μM (B) Induced CD spectra of TMPyP4 (40 
μM) on changing the [TMPyP4]/[(TTAGGG)8TT] molar ratio. 
 
 
 
The coexistence of these two types of binding modes in the 
quadruplex-TMPyP4 complexes has been previously suggested by 
many authors [119,145], ICD of TMPyP4 in presence of (AG3TT)4 
is positive at low [drug]/[DNA] molar ratio and decreases in 
magnitude on increasing the DNA concentration becoming 
negative for [drug]/[DNA]>4 (Figure 3.11). This behaviour is 
different from the one observed in presence of (TTAGGG)8TT 
suggesting the presence of significant difference in the binding of 
TMPyP4 to the two DNA sequences.  
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Figure 3.11  ICD spectra are for TMPyP4 (40 µM) on changing the 
[TMPyP4]/[(AGGGTT)4] molar ratio. 
 
 
 
3.2.1.c. Fluorescence titration experiments 
 
The fluorescence properties of TMPyP4 were studied to get more 
information on their binding to the DNA telomeric sequences.  
TMPyP4 was excited at 435 nm and emission spectrum was 
recorded in the range 550–800 nm. The association processes 
between the quadruplex structures and drugs were studied by 
following the change in fluorescence on changing DNA 
concentration. The titrations were carried out by stepwise addition 
of DNA solutions to a cell containing drug solution. The 
concentration of TMPyP4 was 0.2 μM.  
Figure 3.12 shows the changes in the fluorescence spectrum of 
TMPyP4 on increasing the amount of (TTAGGG)8TT and 
(AG3TT)4 concentration. Adding (TTAGGG)8TT to the TMPyP4 
solution, the structureless emission spectrum of the free drug 
changes into a two-band spectrum and its maxima and the 
minimum become more marked on increasing DNA concentration 
(Figure 3.12A). In particular, a significant increase of the emission 
intensity at 660 nm, a large decrease at 690 nm with an associated 
much smaller decrease of the emission intensity at 720 nm, was 
observed. A similar behaviour has been previously reported for the 
TMPyP4 binding to other G-quadruplex structures [138,128,147]. 
The inset of Figure 3.12A depicts the binding curve obtained by 
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plotting the fraction of bound ligand (α) against the 
[(TTAGGG)8TT] concentration (equation 2, chapter 2, paragraph 
2.3). The binding curves were fitted with the equation 4 (chapter 2 
paragraph 2.3) [148,119]. The binding constant obtained is 5.0×10
6 
M
−1
 and a stoichiometry of 4:1 in agreement with the results 
derived by ITC method.  
 
 
 
 
Figure 3.12  (A) Fluorescence spectra of TMPyP4 in absence and presence of 
successive additions of (TTAGGG)8TT at 25 °C. (B)Fluorescence titration 
spectra of in absence and presence of successive additions of (AG3TT)4 at 25 °C. 
Arrows indicates the increasing DNA concentrations. The concentrations of 
TMPyP4 were 8 μM 0.2 μM. The insets are the plot of the fraction of TMPyP4 or 
azatrux bound (α) vs the [DNA] concentration, the black square represents the 
experimental data and the red line is the theoretical curve obtained on the basis 
of independent and equivalent-sites model. The excitation wavelength is 435 nm. 
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Examination of the Job plot (Figure 3.13A) shows several slope 
changes between approximately linear regions. The intersection 
points are at TMPyP4 mole fractions of 0.5, 0.67 and 0.8 
corresponding to stoichiometric ratios of 1:1, 2:1 and 4:1. 
Although, the final TMPyP4:(TTAGGG)8TT stoichiometry is 
consistent with the overall stoichiometry determined by ITC and 
previous fitting of the fluorescence binding curve, this analysis 
gives more information on the binding process showing the 
presence of three separate binding events: the first two involve one 
TMPyP4 molecule and the last binding involves two TMPyP4 
molecules. This analysis suggests the presence of different binding 
modes for TMPyP4 in agreement with the ICD results. 
 
 
 
 
Figure 3.13  Job plots analysis of fluorescence binding data for the binding of 
TMPyP4 to (TTAGGG)8TT (A) and to (AGGGTT)4 (B). In all the experiments, 
the total molar concentration ([ligand]+[DNA]) was kept constant at 2 µM. The 
excitation wavelength is 435 nm. 
 
 
 
Figure 3.12B shows the change in fluorescence spectrum of 
TMPyP4 on increasing (AG3TT)4 concentration. An increase of the 
emission intensity at all the wavelength associated with a more 
marked increase of the emission intensity at 660 nm resulting in 
final spectrum with a peak centered at 660 nm and a shoulder at 
720 nm, was observed. The fitting of the binding curve (inset of 
Figure 3.12B) results in a TMPyP4:DNA stoichiometry of 4:1 and 
a binding constant of 1.0 × 10
7 
M
−1
. Also in this case, the Job plot 
analysis allowed us to separate the total stoichiometry in two 
separate binding events at TMPyP4 mole fractions of 0.5 and 0.8 
(Figure 3.13B), corresponding to stoichiometric ratios of 1:1 and 
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4:1. In the first binding event one TMPyP4 molecule binds to 
(AG3TT)4 quadruplex, in the second binding event other three 
TMPyP4 molecules bind the (AG3TT)4 quadruplex in agreement 
with the reported ITC results. 
 
 
 
3.2.1.d. UV–vis absorption titration experiments 
 
Binding of TMPyP4 to the multimeric (TTAGGG)8TT quadruplex 
structure was investigated also by UV–Vis titration experiments. 
The spectra were recorded in the 350–500 nm range at 25°C. 
Figure 3.14A shows the absorbance of TMPyP4 on increasing 
(TTAGGG)8TT concentration. An isosbestic point at 435 nm was 
observed. The presence of an isosbestic points, indicative of 
equilibrium between the bound and free ligand, has been already 
reported for UV titration experiments of TMPyP4 to G-quadruplex 
[119,138]. 
UV–Vis spectra of TMPyP4 on increasing DNA concentration 
show a red shift in the absorbance maximum from 422 nm to 434 
nm and a hypochromicity of ∼35%. Comparable values of red shift 
and hypochromicities have been previously observed for other 
quadruplexes and suggested to be diagnostic of an end-stacking 
binding mode of TMPyP4 [119,138]. Job plot of TMPyP4 (Figure 
3.14B) shows a break at 0.8 (mole fraction TMPyP4) 
corresponding to a 4:1 binding stoichiometry. 
 
 
 
 
Figure 3.14  (A) UV absorption spectra of TMPyP4 in the absence and presence 
of (TTAGGG)8TT at 25°C (B) Job plot for the binding of TMPyP4 to 
(TTAGGG)8TT. The total [TMPyP4+DNA] concentration was 2 μM. 
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3.2.2. Discussion and Conclusions 
 
TMPyP4 has been chosen to explore the binding properties of 
higher-order human telomeric  multimer in comparison with the 
single quadruplex structure. (TTAGGG)8TT was used as multimer 
forming sequence, this sequence have been previously 
characterized and it forms a two-quadruplex structure. In particular, 
a high-resolution structural model have been previously suggested 
for this sequence consisting of two mixed-type quadruplex 
structures with a characteristic quadruplex–quadruplex interface 
stabilized by stacking interactions [64]. As single quadruplex,was 
used the (AG3TT)4  quadruplex which has been previously studied 
from a structural point of view and it forms the mixed-type Hybrid-
2 intramolecular quadruplex [56,118]. The ITC and fluorescence 
experiments show that four TMPyP4 molecules are able to bind the 
(TTAGGG)8TT dimeric structure, this corresponds to two TMPyP4 
molecules bound for each quadruplex unit in the dimer. The 
comparison of this value, with the 4:1 stoichiometry, reported for 
the binding to the single (AG3TT)4  quadruplex, suggests that some 
binding sites available in the isolated quadruplex structure are not 
available for the binding when the quadruplex is followed by an 
adjacent quadruplex unit in the (TTAGGG)8TT structure. This 
observation demonstrates that, at least with respect to the binding 
properties, the two quadruplex units in the (TTAGGG)8TT 
structure do not behave as completely independent units. 
Interestingly, two binding events are reported for the (AG3TT)4  
quadruplex involving one and three TMPyP4 molecules whereas 
only one binding event was observed for (TTAGGG)8TT. The 
binding constants and thermodynamic parameters observed for the 
TMPyP4 binding to the (TTAGGG)8TT are similar to the ones 
observed for the lower affinity binding in (AG3TT)4 and no higher 
affinity binding site was observed. This observation, together with 
the observed decrease of binding sites per quadruplex unit, 
suggests that the presence of an adjacent quadruplex in the 
(TTAGGG)8TT structure negatively affects the binding of the 
TMPyP4 to each quadruplex subunit. This effect could result from 
the steric hindrance due to the presence of the adjacent quadruplex. 
In this hypothesis, the quadruplex–quadruplex interface is not 
involved directly in the binding process and its effect on the 
binding is to reduce the number of available binding sites in the 
quadruplex subunits. This hypothesis is consistent with the absence 
of CD changes upon TMPyP4 binding suggesting that the binding 
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does not involve major conformational changes of the 
(TTAGGG)8TT structure as it could be expected for a binding 
involving the quadruplex–quadruplex interface. In a previous study 
have been suggested a (TTAGGG)8TT structural model consisting 
of two adjacent mixed-type quadruplex structures [64]. It was 
shown that the formation of the quadruplex–quadruplex interface in 
the (TTAGGG)8TT structure involves one quadruplex end and a 
lateral loop for each quadruplex subunit (Figure 3.15). These 
structural elements are available binding sites for TMPyP4 in the 
monomeric quadruplex but could be not available to the binding 
(they represent the lost binding sites) in (TTAGGG)8TT due to 
their involvement in the quadruplex–quadruplex interface. On the 
other hand, inspection of the (TTAGGG)8TT structural model 
(Figure 3.15) reveals several possible binding sites not involved in 
the quadruplex–quadruplex interface and that can remain 
unaffected by the presence of the adjacent quadruplex: the two 
propeller loops (one for each quadruplex unit), the quadruplex 
grooves and the G-tetrads at the 5′ and 3′ ends of the 
(TTAGGG)8TT structure. The ability of TMPyP4 to bind 
externally through stacking interaction with the TTA loop bases 
(external binding mode) has been proved by crystallographic 
methods whereas the terminal G-tetrads have been proposed as 
possible binding sites (end-stacking binding mode) on the basis of 
structural, spectroscopic, calorimetric and computational studies 
[119,134,149,135]. The binding of TMPyP4 in these sites can 
happen without any steric hindrance between bound ligands as the 
two propeller loops, and the G-tetrads at the 5′ and 3′ ends, are 
situated on opposite sides in the (TTAGGG)8TT structural model 
(Figure 3.15).  
This picture is consistent with the CD results showing that the 
binding occurs without any structural change in the (TTAGGG)8TT 
structure. Further, the complex behaviour of the ICD of bound 
TMPyP4 on varying the [TMPyP4]/[DNA] ratios is consistent with 
the presence of an end-stacking binding mode (negative ICD) and 
an external binding mode (positive ICD) [150,144,145,146]. 
The external binding mode is probably characterized by lower 
affinity as its contribution to the ICD appears at higher 
[TMPyP4]/[DNA] ratio. The observed ICD at higher 
[TMPyP4]/[DNA] ratio could be also consistent with a TMPyP4 
binding to the quadruplex grooves. The presence of an end-staking 
binding of TMPyP4, wherein the aromatic planar rings of TMPyP4 
stack over the terminal G-tetrads of the (TTAGGG)8TT structure, 
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is also suggested by the high hypochromicities and large 
bathochromic shift observed in the UV titration experiments [134]. 
 
 
 
 
 
Figure 3.15  Scheme showing (TTAGGG)8TT structure along with the proposed 
TMPyP4 binding sites. The schematic dimer structure was built following the 
(TTAGGG)8TT structural model previously reported [64]. 
 
 
 
In summary, there is a decrease of the binding site available for 
each quadruplex unit and the remaining ones are unaffected by the 
presence of the adjacent quadruplex. Although has not been 
observed an improved selectivity when targeting with TMPyP4 to 
the (TTAGGG)8TT multimeric quadruplex instead of the 
monomeric one. The results show that i) the quadruplex units in the 
multimeric structure do not behave as independent with respect to 
their binding properties, ii) the presence of adjacent quadruplexes 
can result in a diverse binding ability not predictable from single 
quadruplex binding studies. It should be noted that TMPyP4 is 
known as monomeric quadruplex ligand, not appositely designed to 
bind a multimeric structure. A drug design process based on a 
multimeric structure as target structure may provide a new route to 
enhance both affinity and selectivity for DNA telomeric 
quadruplexes. 
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CHAPTER 4 A hydrophilic three side-
chained triazatruxene as a new G-quadruplex 
ligand 
 
 
 
 
4.1. Interaction between triazatruxene derivative 
(azatrux)  and  human telomeric G-quadruplex 
under molecular crowding conditions. 
 
A combination of experimental and computational techniques have 
been employed here to fully characterize the binding of a 
triazatruxene based G-quadruplex ligand (azatrux) to the parallel 
G-quadruplex formed by the d[AGGG(TTAGGG)3TT] human 
telomeric DNA sequence under molecular crowding conditions. 
40% PEG solution has been used to simulate crowding conditions 
and to induce the parallel G-quadruplex conformation to form [63]. 
Azatrux is a triazatruxene derivative with three side-chains (Figure 
4.1B), a highly hydrosoluble compound, that has been previously 
designed to bind to the parallel G-quadruplex topology [151]. 
The mode of azatrux binding to the parallel human telomeric 
quadruplex was investigated by CD, UV, fluorescence 
spectroscopy and the energetics of the binding was characterized 
by means of isothermal titration calorimetry (ITC). The dynamic 
and structural features of the azatrux-DNA complex were explored 
by means of molecular modeling methods. Further, the binding of 
azatrux to the parallel human telomeric G-quadruplex was 
compared with binding to the “standard” parallel quadruplex 
formed by the d(TGGGGT) sequence. Finally, the selectivity of 
azatrux for the human telomeric G-quadruplex relative to another 
biologically relevant G-quadruplex (c-Kit87up) and to duplex DNA 
was also evaluated under molecular crowding conditions.  
Quadruplex and duplex samples were prepared by dissolving the 
lyophilised compound in a buffer solution containing 20 mM 
phosphate with 70 mM KCl, 0.1 mM EDTA, 40% (w/v) of PEG 
200, at pH 7.0. The d(TGGGGT) quadruplex samples were also 
prepared in the same buffer described above but in the absence of 
PEG 200. The resulting solutions were annealed by heating at 95 
°C for 5 min. The solutions were then slowly cooled to room 
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temperature and equilibrated for 1 day at 4 °C. The concentration 
of oligonucleotides was determined by UV adsorption 
measurements at 90 °C using molar extinction coefficient values 
ε(260nm) of 245100, 57800, 110700 and 226700 M
−1
 cm
−1
 for 
d[AGGG(TTAGGG)3TT], d(TGGGGT), d(CGCGAATTCGCG) 
and d(AGGGAGGGCGCTGGGAGGAGGG), respectively. The 
molar extinction coefficients were calculated by the nearest 
neighbour model [139]. 5,10,15-tris [4(1-piperidino) butyl] 
diindolo [3,2-a:3′,2′-c] carbazole (azatrux) was synthesized as 
reported in literature [151] and solutions were prepared in the same 
buffer as used for the oligonucleotides. The concentration has been 
estimated by UV spectroscopy using the calculated extinction 
coefficient value ε(313nm) of 48,000 M
−1
 cm
−1
. 
 
 
 
 
 
Figure 4.1 (A) Schematic representation of the unimolecular parallel G-
quadruplex structure assumed by the DNA human telomeric sequence in 
crowding condition. (B) Azatrux chemical structure. 
 
 
 
 
4.1.1. Results 
 
 
4.1.1.a. Binding properties of azatrux to human 
telomeric quadruplex under molecular 
crowding conditions 
 
Fluorescence and UV spectroscopic methods were used to 
investigate the binding of azatrux to the parallel G-quadruplex 
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structure formed by the d[AGGG(TTAGGG)3TT] human telomeric 
DNA sequence under molecular crowding conditions. Figure 4.2A 
shows the fluorescence spectra of azatrux with increasing 
[DNA]/[azatrux] molar ratio. Free azatrux has a fluorescence 
maximum at 394 nm when excited at 321 nm. A decrease in 
fluorescence on increasing DNA concentration, but no change in 
spectral shape, was observed. A binding curve was obtained by 
plotting the fraction of ligand bound as a function of the DNA 
concentration (Figure 4.2A). The curve was fitted using a multiple 
and independent binding site model, by means of nonlinear 
regression algorithm, giving a 1:1 stoichiometry and a binding 
constant of 8 × 10
6
 M
−1
. 
 
 
 
 
 
Figure 4.2  (A) Fluorescence emission spectra of 8 μM azatrux solution in the 
absence and presence of successive additions of telomeric quadruplex (inset), 
and plot of the fraction of azatrux bound vs. the DNA concentration. (B) UV–Vis 
absorption titration spectra of 7 μM azatrux solution in the absence and 
presence of successive additions of telomeric quadruplex. The DNA 
concentration was varied between 0 and 20 μM, and plot of the fraction of 
azatrux bound vs. the DNA concentration (inset). The black squares represent 
the experimental data, the solid line is the best fit obtained with an independent 
sites model. All the titration experiments were performed at 25 °C in buffer 
solution containing 20 mM phosphate with 70 mM KCl, 0.1 mM EDTA and 40% 
(w/v) of PEG 200 at pH 7.0. 
 
 
 
UV–Vis spectra of azatrux with increasing DNA concentration 
show a red shift in the absorbance maximum from 313 nm to 317 
nm and a hypochromicity of ∼30% (Figure 4.2B). The observation 
of isosbestic points at 321 nm, 329 and 337 nm clearly indicates the 
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existence of equilibrium in the binding with the presence of both 
free and bound ligand in solution. The strong hypochromicity 
observed suggests a mode of binding that involves a stacking 
interaction between the azatrux aromatic core and the G-quartets of 
the quadruplex. The binding curve was obtained by plotting the 
fraction of ligand bound as a function of the DNA concentration 
(Figure 4.2B, inset). Analysis of the curve with a multiple and 
independent binding sites model resulted in a 1:1 stoichiometry and 
a binding constant of 1 × 10
6
 M
−1
. 
In the presence of 40% PEG 200, the CD spectrum shows the 
characteristic shape attributed to the parallel fold with a maximum 
around 264 nm and a minimum at 241 nm (Figure 4.3). This result 
is consistent with earlier reports, indicating that PEG 200 is able to 
induce the parallel fold in a number of quadruplex-forming 
oligonucleotide [96,63]. It was found that the addition of azatrux to 
the quadruplex has a small effect on the CD spectrum, as 
demonstrated by the comparison between the CD spectrum of the 
free quadruplex and of the 1:1 complex with azatrux (Figure 4.3). 
This result shows that the binding of azatrux does not significantly 
alter quadruplex topology. 
 
 
 
 
Figure 4.3  CD spectra of the human telomeric quadruplex in crowding 
conditions (solid line), together with its 1:1 complex with azatrux (dashed line). 
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ITC experiments have been performed in order to further 
characterize the thermodynamics of azatrux binding to the parallel 
human G-quadruplex structure [152]. In each titration, volumes of 
5–10 μL of a solution containing 160–200 μM azatrux were 
injected into a solution of quadruplex DNA (10–20 μM) in the 
same buffer, using a computer-controlled 250 μL micro-syringe. 
The resulting binding curve was monophasic, revealing a single 
binding event at 1:1 stoichiometry (Figure 4.4). The experimental 
data were fitted to a single-site model. The thermodynamic 
parameters for the binding are shown in Table 4.1. The 
thermodynamic signature of the binding (inset in Figure 4.4) 
reveals that the binding is enthalpically driven, suggesting that the 
complex is stabilized by the formation of favorable interactions 
between azatrux and G-quadruplex. The value of the ITC binding 
constant is in excellent agreement with the values determined by 
fluorescence and UV–Vis spectroscopy. The negative entropic 
contribution found for the binding suggests that the resulting 
complex is more rigid than the free quadruplex. 
 
 
 
 
 
Figure 4.4  Binding isotherm for the titration of d[AGGG(TTAGGG)3TT] human 
telomeric quadruplex with azatrux obtained by ITC at 25 °C in buffer solution 
containing 20 mM phosphate with 70 mM KCl, 0.1 mM EDTA and 40% (w/v) of 
PEG 200 at pH 7.0. The open circles represent the experimental data obtained 
by integrating the raw data and subtracting the heat of ligand dilution into the 
buffer. The red line represents the best fit obtained by a nonlinear least-squares 
procedure based on a single site model. The inset represents the thermodynamic 
signature of the corresponding interaction. The enthalpic contribution (ΔH°) is 
shown in green, the entropic one (TΔS°) in red, and the Gibbs energy change 
(ΔG°(298K)) in blue. 
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Quadruplex n Kb (M
−1
) 
ΔbH° 
(kJ mol
−1
) 
TΔbS° 
(kJ mol
−1
) 
∆bG°(298K) 
(kJ mol
−1
) 
Under molecular crowding conditions 
d[AGGG(TTAGGG)3TT] 1.1 3.1 × 10
6
 −108 −71 −37 
d[(TGGGGT)]4 1.9 3.6 × 10
6
 −48 −11 −37 
 
In dilute conditions 
d[(TGGGGT)]4 2.0 2.0 × 10
5
 −1 28 −29 
 
Table 4.1  Thermodynamic parameters for the interaction of azatrux with G-
quadruplex structures determined by ITC at 25 °C. (The experimental error for 
each thermodynamic property is <8%) 
 
 
 
4.1.1.b. Molecular model of the complex between 
azatrux and the human telomeric quadruplex 
 
Molecular modeling methods were used to examine the molecular 
basis for the quadruplex binding of azatrux. Molecular modelling 
studies were performed in collaboration with Prof. Neidle at the 
School of Pharmacy of London during a research period in London, 
with the supervision of Dr. Shozeb Haider. 
The crystal structure of the 22-mer human telomeric G-quadruplex 
DNA d[AGGG(TTAGGG)3] (PDB code 1KF1) was used as the 
template for modeling studies. The parallel topology of the 
structure results in propeller TTA loops, with the G-quartets at both 
5′ and 3′ ends being potential binding sites for azatrux. The 
terminal A at the 5′-end was removed using the BUILDER module 
of INSIGHT II package (www.accelrys.com) in order to generate a 
21-mer [67]. K
+
 ions are required to stabilize a quadruplex and are 
located in the crystal structure between the G-quartets, in a vertical 
alignment along the long axis in the central electronegative channel 
of the quadruplex. The binding sites in the model were defined by 
creating two subsets, one each at the 3′ and 5′ ends of the 
quadruplex. A molecular model of azatrux was built using the 
Builder module in the INSIGHT II molecular modeling program 
suite and partial charges calculated semi-empirically using 
MOPAC [67]. 
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The ligand was minimized and docked into both binding sites using 
the CCF (Cornell Force Field) parameter set and then subjected to 
molecular-mechanics energy minimization (1000 steps) via the 
Discover program in the INSIGHT II suite. The minimized ligand 
was then docked in the binding sites using the Affinity docking 
module in INSIGHT II. The potentials were set for the ligand and 
the DNA using the CCF force field. The simulated annealing 
docking was run with 500 iteration steps, allowing ten structures to 
be generated and one accepted. The most probable conformation 
for the ligand in each structure was chosen and ranked, based on 
detailed considerations of optimal binding states. Initially, the 
azatrux conformation with the highest interaction energy was 
chosen as a starting point. This chosen conformation was then 
qualitatively analyzed based on the position and orientation of the 
docked ligand in relation to the terminal G-quartets. If the chosen 
conformation of the ligand did not result in a good stacking 
arrangement with the G-quartet the docked complex was discarded 
and the conformation with the next highest interaction energy value 
was analyzed. This procedure was repeated until a stable 
conformation with optimal G-quartet stacking was identified. The 
G-quartets were kept frozen in their original conformation 
throughout the docking procedure. This is a valid approximation 
because the G-quartet platform has been previously shown in a 
number of experimental and simulation studies to be exceptionally 
stable and structurally rigid [62,91,153]. The most favourable 
complex was selected from the docked structures on the basis of 
the calculated binding energies after energy minimization and 
corresponds to the azatrux docked on the 3′-end of the quadruplex 
structure. This result is probably due to two reasons: (a) firstly the 
orientation of the TTA loops create grooves that are deeper and 
accessible to ligand substituents when bound at the 3′ end and (b) 
the 5′- 3′ strand polarity generated by the propeller loop topology 
exposes the phosphodiester backbone on this side and thus making 
the 3′ end more polar and favourable to interact with ligands with 
positively-charged side chains. The most favourable complex 
between azatrux and G-quadruplex DNA was chosen on the basis 
of highest interaction energy and orientation of the ligand around 
the terminal G-quartet (Figure 4.5A). This model was then used for 
further analysis. The model shows that the azatrux core makes 
extensive π–π-stacking interactions with the terminal G-quartet. 
Furthermore, two of the three N-butyl-piperidine side-chain 
substituents of azatrux lie in the grooves formed by the TTA loops. 
 81 
 
The positively-charged nitrogen atoms of the piperidine rings can 
interact with phosphate groups in the phosphodiester backbone. 
The length and in particular the geometric relationship of the three 
side-chains prevent the third one from fully accessing the grooves. 
This side-chain instead sits on top of the terminal G-quartet and 
also makes favourable interactions with the phosphodiester 
backbone (Figure 4.5A). 
 
 
 
 
 
Figure 4.5  A) Top view of azatrux making π–π stacking interactions with the 
terminal G-quartet, with colour based on electrostatic potential, red (negative) 
and blue (positive). Two ligand side chains are shown positioned in the grooves 
created by the TTA loops (indicated by arrows) and the third positioned over the 
phosphodiester backbone from the terminal G-quartet. (B) The charged nitrogen 
atoms of the piperidine side chain end-groups (a and b) are in close hydrogen-
bonding/electrostatic contact with backbone phosphate groups in two grooves, 
while the third is positioned on top of the sugar-phosphate backbone on the 
terminal G-quartet 
 
 
 
15 ns molecular dynamics simulations of the propeller-type 
parallel-stranded G-quadruplex DNA and the azatrux–quadruplex 
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complex have been performed to assess the stability contributed by 
the binding of azatrux. 
The  21-mer native and G-quadruplex complexes docked with 
azatrux on the 3′ end were subjected to molecular dynamics 
simulation using the Amber parmbsc0 force field ported to the 
Gromacs package. The models were solvated in a periodic TIP3P 
water box of dimensions whose boundaries extended at least 10 Å 
from any solute atom. Additional positively-charged K
+
 counter-
ions were included in the system to neutralize the charge on the 
DNA backbone. These maintained consistency with the 
crystallization conditions and hence simulated a uniform K
+
 ionic 
environment. Each system was equilibrated with explicit solvent 
molecules by 1000 steps of minimization and 0.5 ns of molecular 
dynamics at 300 K. The entire systems were kept constrained, 
allowing the ions and the solvent molecules to equilibrate. They 
were then subjected to a series of dynamics calculations in which 
the constraints were gradually relaxed, until no constraints at all 
were applied. The final two production runs were performed for 15 
ns without any restraints on the systems and co-ordinates were 
saved after every 5 ps for analysis of their trajectories [154]. These 
were analyzed using the Gromacs analysis tools, visualized by 
means of the VMD program [155] and graphs plotted using the 
Xmgrace program (http://plasma-gate.weizmann.ac.il/Grace/). 
The root mean square deviation (RMSD) calculated from the 
simulation is a good indicator of the conformational stability of the 
simulated models. The result of these simulations, as revealed from 
the RMSD plots (Figure 4.6A), indicate that the azatrux-G-
quadruplex complex is more stable than the G-quadruplex alone, 
with RMSDs of 2.3 Å and 2.7 Å, respectively. The role of the 
positively-charged side chains in the stabilization of the azatrux-G-
quadruplex complex was also explored. The interactions between 
the piperidine side chains and the negatively-charged 
phosphodiester backbone were sampled over the course of the 15 
ns simulation time. Figure 4.6B shows the distances between the 
positively-charged nitrogen atoms in the N-butyl piperidine side 
chains of the ligand and the negatively-charged oxygen atoms in 
the phosphodiester backbone of the quadruplex, calculated over the 
course of the 15 ns simulation. The two side chains that are 
positioned in the groove maintain stable interactions during the 
greater part of the simulation. This is due to the lack of rotation 
around the piperidine group in the side chain. However, the third 
side chain that is partially positioned over the G-quartet is highly 
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flexible. The molecular dynamics simulations highlight the ability 
of these side-chains to make multiple interactions with the 
phosphodiester backbone during the course of the simulation. 
These interactions impart rigidity to the interacting sugar-
phosphate backbone and also provide a structural rationale for the 
stabilization of a propeller-type parallel stranded topology by 
azatrux. 
 
 
 
 
Figure 4.6  (A) Root mean square deviation (RMSD) plot comparing the stability 
of the parallel-stranded G-quadruplex DNA (black) and azatrux-G-quadruplex 
complex (red). Analysis of the trajectories suggests that the azatrux-G-
quadruplex complex structure is more stable than the native structure. (B) The 
distance calculated between the positively charged nitrogen atom in piperidine 
ring at the terminus of each ligand side chain of the ligand and the negatively-
charged phosphate oxygen atoms in the phosphodiester backbone of the 
quadruplex, calculated over the course of the 15 ns simulation time. The three 
different colours represent the interactions for three different side chains of the 
ligand with the quadruplex. Side chains that fit in the groove (red and blue) 
make stable interactions while the side chain that sits on top of the 
phosphodiester backbone is relatively flexible. 
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4.1.1.c. Binding of azatrux to the parallel 
[d(TGGGGT)]4 quadruplex 
 
To test the ability of azatrux to bind with an end-stacking mode to a 
parallel G-quadruplex topology, azatrux binding to a “standard” 
parallel G-quadruplex, the one formed by the d(TGGGGT) 
sequence in K
+
 solution, has been examined [156]. The 
[d(TGGGGT)]4 quadruplex has all-anti G-quartets, as in the 
parallel intramolecular 22-mer human telomeric quadruplex. The 
advantage of using the d(TGGGGT) sequence is that it forms a 
parallel tetramolecular quadruplex in dilute conditions (in the 
absence of PEG 200). This enables NMR titration experiments 
performed (NMR experiments are not straightforward in molecular 
crowding conditions) to determine structural features of the binding 
mode of azatrux to parallel quadruplexes. NMR experiments were 
performed by Prof. A. Randazzo at the School of Pharmacy of 
University of Naples.  
To compare the thermodynamic parameters derived for the binding 
of azatrux to the human telomeric sequence with the ones for the 
binding to [d(TGGGGT)]4 quadruplex, ITC experiments were 
performed with [d(TGGGGT)]4 in the presence and absence of 
PEG. ITC binding curves are monophasic and very similar in both 
instances (Figure 4.7).  
The interpolation procedure with the experimental data has been 
carried out with a single set of identical sites model. In both 
crowding and dilute conditions, the stoichiometry of the azatrux-
DNA complex is 2:1, confirming the stoichiometry obtained by 
NMR titration experiments. Interestingly, the thermodynamic 
parameters and the binding constant are different in the absence 
and presence of PEG. Particularly, the binding event is 
enthalpically driven in the presence of PEG and entropically driven 
in its absence, as shown by the thermodynamic signature of the 
processes (Table 4.1 and Figure 4.7). In the presence of PEG, the 
binding free energy change is more favourable and the 
corresponding binding constant is an order of magnitude higher 
than in the absence of PEG, indicating that crowding conditions 
increase ligand affinity for the quadruplex structure. 
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Figure 4.7  Normalized heat of interaction between azatrux and the 
[d(TGGGGT)]4quadruplex obtained by ITC at 25 °C in a buffer solution 
containing 20 mM phosphate with 70 mM KCl, 0.1 mM EDTA, at pH 7.0, (A) in 
the presence of 40% PEG 200 or (B) in the absence of PEG. The open circles 
represent the experimental data obtained by integrating the raw data and 
subtracting the heat of ligand dilution into the buffer. The red line represents the 
best fit obtained by a nonlinear least-squares procedure based on a multiple and 
independent sites model. The insets represent the thermodynamic signature of 
the corresponding interaction: the enthalpic contribution (ΔH°) is shown in 
green, the entropic one (TΔS°) in red, and the Gibbs energy change (ΔG°298K) in 
blue. 
 
 
 
Since crowding conditions do not affect the parallel fold of the 
[d(TGGGGT)]4  quadruplex, as shown by the CD spectrum (Figure 
4.8), this effect can be directly correlated with the reduced water 
activity in PEG solution. The comparison of the binding constants 
and free energies (Table 4.1) obtained in crowding conditions for 
the d[AGGG(TTAGGG)3TT] and [d(TGGGGT)]4 quadruplexes, 
reveals that the azatrux binds these two quadruplex structures with 
similar affinity, thus suggesting the same binding mode. 
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Figure 4.8  CD spectra of the [d(TGGGGT)]4 quadruplex in dilute solution 
(dotted line) and in crowding conditions (solid line). 
 
 
 
Finally, the same set of UV–Vis and fluorescence titration 
experiments performed with the human telomeric quadruplex was 
performed on the [d(TGGGGT)]4 quadruplex both in presence and 
absence of PEG. Figure 4.9 shows the UV and fluorescence 
titration experiments and the corresponding binding curves in both 
presence and absence of PEG. In all cases, the observed changes in 
the UV–Vis and fluorescence spectra of azatrux upon addition of 
[d(TGGGGT)]4 were very similar to the ones observed for the 
human telomeric sequence. Fitting of the binding curves with an 
independent and equivalent binding sites model confirms the 2:1 
stoichiometry value found in the ITC experiments. The binding 
constants were: 4 × 10
6
 M
−1
 (UV in absence of PEG), 4 × 10
6
 M
−1
 
(UV in presence of PEG) and 9 × 10
6
 M
−1
 (fluorescence in absence 
of PEG) and 4 × 10
6
 M
−1
 (fluorescence in presence of PEG). 
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Figure 4.9  (A, B) UV–Vis absorption titration spectra of azatrux solutions in the 
absence and presence of successive additions of [d(TGGGGT)]4 quadruplex. The 
insets show the plot of the fraction of azatrux bound vs. the DNA concentration. 
(C, D) Fluorescence emission spectra (insets) of azatrux solutions in the absence 
and presence of successive additions of [d(TGGGGT)]4 quadruplex, and plot of 
the fraction of azatrux bound vs. the DNA concentration. The black squares 
represent the experimental data, the solid line is the best fit obtained with an 
independent sites model. All the titration experiments were performed at 25 °C 
in buffer solution containing 20 mM phosphate with 70 mM KCl, 0.1 mM EDTA 
and 40% (w/v) of PEG 200 at pH 7.0. 
 
 
 
4.1.1.d. Binding of azatrux to other biologically 
relevant DNA structures 
 
The selectivity of azatrux for DNA quadruplex over DNA duplex 
was explored studying its affinity for the DNA duplex formed by 
the d(CGCGAATTCGCG) oligonucleotide. The UV spectrum of 
azatrux does not change on increasing DNA duplex concentration 
(Figure 4.10), suggesting that azatrux does not interact with duplex 
DNA.  
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Figure 4.10  UV-vis absorption spectra of (black line) 4 µM azatrux solution 
and (red line) of azatrux in the presence of an excess of duplex DNA (10 µM). 
The two spectra are superimposable. 
 
 
 
To evaluate the selectivity of azatrux for telomeric quadruplex over 
other biologically relevant quadruplex structures, its affinity for the 
c-Kit87up quadruplex was also explored. Fluorescence spectra of 
azatrux were recorded on increasing c-Kit87up concentration and 
the corresponding binding curves were fitted by means of an 
independent and equivalent site model (Figure 4.11). A 
stoichiometry of 2:1 and a binding constant of 5 × 10
5
 M
−1 
were 
found, revealing a weaker interaction with respect to that found for 
the telomeric quadruplex. 
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Figure 4.11  Fluorescence emission spectra (inset) of 8 µM azatrux solution in 
the absence and presence of successive additions of c-Kit87up quadruplex, in a 
buffer solution containing 20 mM phosphate with 70 mM KCl, 0.1 mM EDTA, 
40% (w/v) of PEG 200, at pH 7.0, and plot of the fraction of azatrux bound vs. 
the concentration of DNA. The black squares represent the experimental data, 
the red line is the best fit obtained with an independent sites model. 
 
 
 
 
4.1.2.  Discussion and Conclusions 
 
Since the parallel fold is likely to be the dominant structure for the 
human telomeric DNA in physiological crowding conditions, it is 
important to understand the structural and energetic features 
governing the binding to this particular G-quadruplex topology. In 
order to induce the parallel topology in the 
d[AGGG(TTAGGG)3TT] human telomeric sequence, crowding 
condition were simulated by adding PEG 200 to the DNA solution. 
Fluorescence and UV titration experiments are consistent with the 
binding of one azatrux molecule to the DNA quadruplex. The CD 
spectrum of the d[AGGG(TTAGGG)3TT] in crowding condition is 
characteristic of the parallel topology and the binding of azatrux 
does not cause conformational change in the quadruplex. This 
observation is consistent with a model in which azatrux binds the 
parallel topology with an “external” binding mode, rather than an 
intercalative binding mode. Further, intercalation between G-
quartets would be sterically prevented by the presence of the 
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propeller loops in the parallel G-quadruplex. However, the large 
hypochromic shift observed in the azatrux UV spectrum upon DNA 
addition suggests a mode of binding that involves extended 
stacking interactions between the azatrux aromatic core and DNA 
bases. The formation of extensive interactions between azatrux and 
DNA is also supported by the ITC data showing a large enthalpy 
change (−108 kJ/mol) upon azatrux binding. A reasonable 
hypothesis thus involves an external binding mode with azatrux 
stacked on the terminal G-quartet plane of the G-quadruplex 
structure. Terminal stacking of small ligands has been observed in 
all crystal structures of quadruplex–ligand complexes [157,91,158], 
and is consistent with other biophysical studies [96,150]. The 
molecular modeling results support this hypothesis in showing that 
the aromatic core of azatrux can efficiently stack on the 3′ terminal 
G-quartet without causing any major deformation of the 
quadruplex structure. This result is consistent with the CD results 
showing that azatrux binding does not change the quadruplex 
conformation. The molecular dynamic study enables the role of the 
N-butyl-piperidine side-chains in the binding to the parallel human 
quadruplex to be explored and indicates that the positively-charged 
nitrogen atoms of two piperidine side-chains interact with the 
negatively-charged phosphodiester backbone. These interactions, 
together with the stacking interaction between the azatrux core and 
the G-quartet surface, are consistent with the large enthalpy change 
observed by ITC for the formation of the azatrux–quadruplex 
complex. On the other hand, as shown by the comparison of the 
RMSD plots from the molecular dynamics simulations, these 
interactions impart rigidity to the interacting sugar-phosphate 
backbone in the complex, compared to the free quadruplex. This 
greater rigidity in the azatrux–quadruplex complex is consistent 
with the negative entropic contribution observed by ITC for the 
azatrux binding process. To further confirm the ability of azatrux to 
bind to the parallel quadruplex topology the binding of azatrux to 
the parallel-stranded [d(TGGGGT)]4 quadruplex was examined. 
This quadruplex has all glycosidic angles populating anti 
conformations, as in the parallel human telomeric sequence under 
crowding conditions, but in contrast forms the same structure in the 
absence of crowding conditions. ITC experiments, performed in 
both the presence and absence of crowding conditions, show that 
azatrux binds the [d(TGGGGT)]4 quadruplex with 2:1 
stoichiometry. NMR data, obtained in the absence of crowding 
conditions, provide evidence for an end-stacking binding mode for 
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the azatrux molecules to each of the two terminal G-quartets. The 
thermodynamic signature of this binding in the presence of PEG 
200 is in agreement with that found for the human telomeric 
sequence, also revealing an enthalpically driven binding process, 
thus suggesting a closely similar binding mode to the two 
quadruplexes. Interestingly, azatrux binds with a 2:1 stoichiometry 
the [d(TGGGGT)]4 quadruplex, but with a 1:1 stoichiometry the 
human telomeric quadruplex. A plausible reason for this 
discrepancy could be the different role played by the thymine bases 
in the two quadruplexes. In the [d(TGGGGT)]4, the thymine bases 
are not structured and very flexible and they probably do not 
participate in the binding of azatrux, making the two terminal G-
tetrads equivalent binding sites for the azatrux molecule. On the 
contrary, molecular modeling shows that, in the human telomeric 
sequence, the presence of the structured loop bases determines 
significant differences in the geometries of the two quadruplex 
extremities, making them not equivalent and allowing the binding 
of azatrux only to the 3‟-end of the G-quadruplex. 
 
 
 
 
 
Figure 4.12  Schematic representation of water molecules associated with the 
side chains of azatrux. There are two solvent molecules associated per chain. 
There is a direct interaction between protonated nitrogen of azatrux and the 
phosphate oxygen atoms. At no point during the course of the simulation a 
water-mediated contact is observed. The dashed lines indicate the interactions 
between the solvent/quadruplex and the ligand. Quadruplex is coloured grey 
with the phosphate backbone and the contributing base in stick representation. 
The water molecules are represented as ball-and-sticks. 
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In conclusion, the experimental and computational results 
presented here support the hypothesis that azatrux preferably binds 
to parallel G-quadruplex structures, by end-stacking, and shows 
that the presence of a planar aromatic surface, as well as the side 
chains are important structural elements in optimizing this binding 
mode. The modeling also suggests that the length of two of the 
five-carbon linker chains in the azatrux molecule is optimal for 
ensuring effective interactions in the grooves. The third side-chain 
cannot reside in a groove due to the incompatibility of the three-
fold pseudo-symmetry of the azatrux molecule with the four-fold 
symmetry of the quadruplex surface. This suggests that studies on 
alternative positions for this third substituent would be able to 
enhance binding and potentially selectivity as well. Further, 
molecular modeling showed the relevance of the electrostatic 
interactions in stabilizing the azatrux–quadruplex complex. This 
suggests that the polarity of the side chains is another critical 
parameter to vary in future studies to further modulate the G-
quadruplex ligand binding properties. 
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CHAPTER 5 Novel classes of potential anti-
cancer agents binding to the grooves of G 
Quadruplex Structures 
 
 
 
 
 
5.1. Selective Binding of Distamycin A Derivative to 
G-Quadruplex Structure (TGGGGT)4 
 
 
In the past decade, a growing number of G-quadruplex binding 
agents have been proposed, most of them interact with the outer G-
tetrads of the structures through π-π stacking interactions [94]. The 
only groove binder experimentally proven to date is the distamycin 
A that interacts in a groove-binding mode with the quadruplex 
[d(TGGGGT)]4. This finding, along with the observation that 
distamycin derivatives could be effective inhibitors of the human 
telomerase [159], has stimulated other investigations. The 
importance of the crescent shape extension has been investigated 
by varying the pyrrole units number in distamycin A [108]. 
Particularly, it has been studied the interaction of two carbamoyl 
analogues of distamycin A, containing four and five pyrrole units, 
respectively. Experiments revealed that the presence of one 
additional pyrrole unit affects the affinity as well as the 
stoichiometry of the binding, whereas the addition of two pyrrole 
units leads to a total loss of interaction between the derivative and 
the [d(TGGGGT)]4.  
The effect of a second cationic group, placed at the end of the 
molecule, on the interaction with DNA molecules, was evaluted. In 
particular, the interaction between the [d(TGGGGT)]4 quadruplex 
and a new distamycin A derivative (compound 1, Figure 5.1), 
where the initial formamide group is replaced by a charged N-
formimidoil moiety have been studied.  
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Figure 5.1 (a) Chemical structures of netropsin, (b) distamycin A, and (c) 
compound 1. 
 
 
 
 
In addition, since compound 1 can also be considered as an 
analogue of netropsin because it presents one pyrrole unit more 
than netropsin (three instead of two), but two cationic ends like it 
(even if different groups), was compared the binding of compound 
1 to [d(TGGGGT)]4 with the binding of netropsin to the same 
target. 
Finally, to investigate the selectivity of compound 1 for the G-
quadruplex relative to duplex, was also performed a study of the 
interaction between the drug and the self-complementary DNA 
duplex d(CGCGAATTCGCG)2. This symmetric dodecamer was 
chosen because (a) it contains the central AATT core, which is 
considered the specific binding site for distamycin and netropsin; 
(b) the interaction with netropsin is well characterized in literature, 
from both structural and thermodynamic point of view. 
Quadruplex and duplex samples were prepared by dissolving the 
lyophilised compound in a buffer solution containing 20 mM 
phosphate with 70 mM KCl, 0.1 mM EDTA at pH 7.0. The 
concentration of oligonucleotides was determined by UV 
adsorption measurements at 90°C using molar extinction 
coefficient values ε(260 nm) of 57800 and 110700 M
−1
cm
−1
for 
d(TGGGGT) and d(CGCGAATTCGCG), respectively.  
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Drug solutions have been prepared in the same buffer used for the 
oligonucleotides, and the concentration has been estimated by UV 
spectroscopy using the calculated extinction coefficient value ε(297
nm) of 30000 M
−1
cm
−1
 for compound 1 and the reported extinction 
coefficient value ε(296 nm) of 21500 M
−1
cm
−1
 for netropsin [160]. 
 
 
 
 
 
5.1.1. Results 
 
 
5.1.1.a. ITC experiments 
 
In Figure 5.2 are reported examples of raw ITC and integrated heat 
data for the titration of [d(TGGGGT)]4 quadruplex with netropsin 
and compound 1 are shown. In each titration, volumes of 5–10 μL 
of a solution containing compound 1 or netropsin at a concentration 
of 600–700 μM were injected into a solution of quadruplex or 
duplex DNA (30 μM) in the same buffer, using a computer-
controlled 250 μL microsyringe. The ITC data for drugs binding to 
[d(TGGGGT)]4 indicate, in both cases, the formation of a 2:1 
(drug:quadruplex) complex with good affinity.  
The raw data for the titration of drugs with [d(TGGGGT)]4 (insets 
in Figure 5.2) indicate an exothermic interaction, based on the 
positive values observed for the peaks. With each injection of 
ligand, less and less heat release was observed until constant values 
were obtained, thus reflecting, in both cases, a saturable process. 
The thermodynamic results, obtained from fitting the ITC data for 
netropsin and compound 1 binding to [d(TGGGGT)]4, are given in 
Table 5.1. 
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Ligand n Kb (M
−1
) 
ΔbH° 
(kJ mol
−1
) 
TΔbS° 
(kJ mol
−1
) 
∆bG°(298K) 
(kJ mol
−1
) 
Compound 1 2.0 ± 0.1 1.9 (± 0.2)× 10
6
 -11.0 ± 2.0 25 ± 2 -36 ± 2 
Netropsin 2.0 ± 0.1 1.2 (± 0.1)× 10
6
 -10.6 ± 1.0 23 ± 2 -34 ± 2 
 
Table 5.1 Thermodynamic parameters for the interaction of compound 1 and 
netropsin with [d(TGGGGT)]4 determined by ITC at 25°C and pH 7.0. 
 
 
 
 
Figure 5.2 Raw ITC data (insets) and binding isotherms for titration of 
[d(TGGGGT)]4 with netropsin (a) and with compound 1 (b). 
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The values of the binding constants and the Gibbs energy changes 
(−34 kJ mol−1 and −36 kJ mol−1 for netropsin and compound 1, 
resp.) indicate that, from a thermodynamic point of view, the 
interactions with the quadruplex molecule are favoured at 25°C.  
The values of ΔH° and TΔS° show that in both cases the 
interactions are associated with a favourable binding enthalpy 
(−10.6 kJ mol−1 and −11.0 kJ mol−1 for netropsin and compound 1, 
respectively), however, the binding processes are always 
entropically driven (23 kJ mol
−1
 and 25 kJ mol
−1
 for netropsin and 
compound 1, respectivily). 
Finally, experiments on the interaction of compound 1 with the 
DNA duplex d(CGCGAATTCGCG)2 containing the central 
“AATT” core, which is considered the specific binding site for 
distamycin and netropsin, to evaluate if the structural modifications 
of compound 1 influence the binding, were performed. An example 
of the raw ITC data for the titration of the d(CGCGAATTCGCG)2 
duplex with compound 1 is shown in Figure 5.3. Resolvable 
binding isotherm was never obtained for the interaction of 
compound 1 with duplex using any combination of reactant 
concentrations, thus suggesting low affinity of the molecule for the 
investigated duplex. 
 
 
 
 
Figure 5.3 Raw ITC data for titration of d(CGCGAATTCGCG)2 duplex with 
compound 1. With each injection of ligand, constant heat release was observed 
due only to ligand dilution. 
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5.1.2. Discussion and Conclusions 
 
Distamycin and netropsin have been recognized for decades as non 
intercalative DNA binding ligands that show specificity for the 
minor groove of dA•dT base pairs [160,161]. The binding of the 
drugs to the duplex DNA involves an electrostatic component from 
the cationic ends, hydrogen bonds from the amide NH groups, and 
van der Waals interactions with the wall of the groove. Some years 
ago, NMR studies indicated that, depending on DNA sequence, 
some binding sites can accommodate two distamycin molecules 
side-by-side in an antiparallel orientation [162]. In this 2:1 complex 
each ligand molecule preserves all the molecular recognition 
elements of groove binders. In contrast to distamycin, the netropsin 
binds only as a single molecule per binding site, suggesting that the 
side-by-side arrangement of two molecules is inhibited by charge 
repulsions. Both drugs have been shown little or no affinity for 
single-stranded DNA or RNA or for double-stranded RNA or 
DNA-RNA hybrids as well as they do not bind to the A helix or the 
left-handed Z-DNA [161,163]. 
Surprisingly, distamycin A has recently been shown to interact also 
with four-stranded parallel DNA quadruplexes [95,164,165]. 
Particularly, it was demonstrated, by using NMR and ITC 
methodology, that distamycin is able to interact with the 
quadruplex [d(TGGGGT)]4. Four ligand molecules bind as 
antiparallel dimers to the quadruplex in two opposite grooves, 
establishing hydrogen bonds with the guanine bases and strong 
coulombic interactions between the positively charged amidinium 
moiety of the ligand and the negative backbone phosphate groups 
of the quadruplex [95]. On the other hand, netropsin turned out to 
possess a lower affinity (NMR data) towards the quadruplex 
[d(TGGGGT)]4 [164], even if, till now, this has never been 
confirmed by ITC. Interestingly, it seems that netropsin is not able 
to bind the quadruplex in dimeric form, most probably due to the 
doubly charged nature of molecule that prevents a side-by-side 
arrangement into the grooves. 
In order to evaluate the binding properties of derivative 1, and to 
perform a direct comparison with the binding behaviour of 
distamycin A and netropsin, [d(TGGGGT)]4 has been titrated with 
1 at the same experimental conditions (buffer, temperature, DNA 
concentration) used for distamycin A [164].  
Isothermal titration calorimetry experiments were performed, 
indeed ITC is the only technique that directly measures the binding 
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enthalpy change for the formation of a complex, allowing the free 
energy change to be dissected into the enthalpic and entropic 
contribution to the association process. This reveals the nature of 
the forces that drive the binding and can provide insight into the 
nature of the intermolecular contacts formed and even into changes 
in solvation [166]. The understanding of those factors can be 
helpful in both screening among various drugs and optimizing the 
drug-target interactions, to direct the design of new drugs. 
ITC experiments reveal that both compound 1 and netropsin bind 
to the investigated quadruplex. The thermodynamic profiles of the 
two drug-quadruplex interactions are qualitatively similar and in 
both cases the stoichiometry observed is 2:1 (drug:quadruplex). 
Interestingly, the thermodynamic parameters determined by ITC 
(Table 5.1) indicate that the association reactions of both ligands 
with [d(TGGGGT)]4 are entropically driven processes, even if the 
direct ITC measurements of the binding enthalpy change indicate 
that also the enthalpic contribution favours the associations. In the 
case of the interaction of distamycin with [d(TGGGGT)]4, similar 
results were obtained (entropically driven process with a small 
favourable enthalpic contribution), except for stoichiometry and 
magnitude of binding constant. 
As reported in the literature many times, a groove binding is 
generally characterized by a large favourable increase of entropy 
and a small favourable or unfavourable enthalpy change [167]. 
This could be mainly due to the fact that the association reaction is 
driven in large part by a hydrophobic effect and the favourable 
entropy is derived from the release of bound water molecules from 
the DNA and drug upon complex formation as well as release of 
counterions upon binding of cationic ligands. Interestingly, the 
entropically driven interactions of the compound 1 and of netropsin 
suggest a groove-binding mechanism also in these cases, as 
observed for distamycin A. Additionally, in contrast to many other 
groove binders, netropsin binding to duplex DNA is accompanied 
on average by a favourable enthalpy change. This is the result of 
both electrostatic interactions and hydrogen bonds formation 
between netropsin molecule and DNA. A favourable enthalpy 
change is observed by ITC for netropsin binding to [d(TGGGGT)]4 
as well as for compound 1, suggesting once again a similar groove 
binding mode. 
As stated before, the stoichiometry obtained for the association of 
the investigated ligands to [d(TGGGGT)]4 is 2:1 (drug :
quadruplex), while for distamycin a stoichiometry of 4:1 was 
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found. This finding is consistent with the observation that the 
distamycin molecules are able to bind as dimers, while netropsin 
(and probably also compound 1) is not able to dimerise because of 
charge repulsions. Notably, in the distamycin-[d(TGGGGT)]4 
complex, each distamycin dimer expands its bounded groove 
(similarly to that observed with duplex DNA), with concomitant 
reduction of the size of the adjacent ones, preventing a further 
interaction with other ligand molecules. In the binding of netropsin 
to duplex DNA the minor groove is widened by 0.5–2.0 Å by the 
entry of the drug [168]. The binding of the two netropsin molecules 
to [d(TGGGGT)]4 could similarly expand the bounded grooves, 
reducing the size of the adjacent ones and preventing more 
interactions. 
The experiments on the interaction of compound 1  with the DNA 
duplex d(CGCGAATTCGCG)2 show that compound 1  has a poor 
affinity for the investigated duplex, while it is well known that both 
distamycin and netropsin have a high binding constant (between 
10
6
 and 10
8
M
−1
) for that target containing the specific binding site. 
Netropsin and compound 1 are able to bind to [d(TGGGGT)]4 with 
good affinity, forming, in both cases, a 2:1 (drug : quadruplex) 
complex. 
Very interestingly, this study shows that the structural 
modifications of compound 1 do not influence, compared to 
netropsin, the interaction with the quadruplex, but such 
modifications decrease the affinity of the ligand toward the duplex, 
thus enhancing the selectivity. 
 
 
 
 
 
5.2. Virtual Screening-derived compounds and the 
G-Quadruplex Structure (TGGGGT)4: an ITC 
study 
 
 
As has been stated before, the evidence that the grooves of a 
quadruplex structure can be recognised by an organic molecule first 
appeared approximately three years ago [95]. An NMR study 
revealed that, distamycin A can bind in a dimeric form to the two 
opposite grooves of the quadruplex [d(TGGGGT)]4 [164]. Whereas 
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the end-stacker ligands are the major part of all known quadruplex 
binders and their number is growing each day, quadruplex groove 
binders represent a quite unexplored and valuable field. In fact, 
grooves in duplex and quadruplex DNA are chemically and 
conformationally different, and since groove dimensions differ 
according to the type of quadruplex, groove binders can in 
principle be selective for a particular quadruplex topology. Thus, 
with the aim of finding brand new molecular scaffolds able to 
interact with the groove, in a previous study was performed an 
extensive structure-based virtual screening (VS) campaign [169], 
starting from the quadruplex structure found in complex with 
distamycin A. As a result, six molecules were found to be 
somehow groove binding agents by NMR and  isothermal titration 
calorimetry (ITC) measurements. The study revealed that one of 
the six compounds is more effective in groove binding with respect 
to distamycin A (Figure 5.4) [170]. 
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Figure 5.4  Structure of the newly identified quadruplex binder as resulted from 
the virtual screening experiment and ITC experiments.  
 
 
 
 
Starting from these results, was performed a thermodynamic study 
of the interaction between G-quadruplex structure [d(TGGGGT)]4 
and fifteen derivatives (G2-G16) of the compound G1 selected in 
the previous study (Figure 5.5).  The interaction has been studied 
by isothermal titration calorimetry (ITC), analysing the 
displacement of these ligands from the grooves of DNA-
quadruplex by Distamycin A, the best groove binder identified 
until now. The d(TGGGGT) and d(CGCGAATTCGCG) 
oligonucleotide sequences used for this study were prepared by 
dissolving the lyophilised compound in 10 mM phosphate buffer 
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with 70 mM KCl, 0.2 mM EDTA, pH 7. The concentration of 
oligonucleotides was determined by UV adsorption measurements 
at 90°C using molar extinction coefficient values ε(260 nm) of 57800 
and 110700 M
−1
cm
−1
for d(TGGGGT) and d(CGCGAATTCGCG), 
respectively. The molar extinction coefficients were calculated by 
the nearest neighbour model [139]. Stock solutions of the sixteen 
drugs were prepared by solubilising weighted amounts in DMSO to 
a final concentration of 8 mM. The complexes between the 
quadruplex and the drugs were prepared diluting the drug stock 
solution into the quadruplex solution to get a final DNA:drug molar 
ratio of 1:4 and a final DMSO concentration of 7%. Distamycin A 
was solubilised in the same buffer used for the oligonucleotide 
containing 7% of DMSO. 
The competition ITC experiments performed, represent a possible 
strategy to evaluate the efficiency of a groove binder compared to 
distamycin A, even if this strategy doesn‟t allow to directly 
measure all the thermodynamic parameters involved in the binding 
processes. 
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Figure 5.5  Structures of the derived compounds from G1 quadruplex binder. 
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5.2.1. Results 
 
 
5.2.1.a. ITC experiments 
 
To investigate the binding affinity of the compounds G1-G16 for 
the [d(TGGGGT)]4 G-quadruplex, ITC experiments were 
performed. Efforts to obtain direct thermodynamic information 
from canonical ITC experiments [152], in which a G-quadruplex 
solution is titrated with  a ligand  solution  in  the  identical aqueous 
buffer, have failed due to solubility issues regarding the ligands. 
Instead of direct measurements, displacement experiments were 
effectively  carried out [171], in which was analyzed the binding of 
distamycin A to the G-quadruplex previously saturated with a 
ligand. Indeed, despite the solubility issues, mixtures of G-
quadruplex with each compound were successfully prepared by 
dissolving the ligands in DMSO and diluting them in the aqueous 
buffer solution containing the G-quadruplex. Once the complex is 
formed, the ligand will inhibit the binding of distamycin A if its 
affinity for the G-quadruplex is higher than the latter, conversely, it 
will be displaced by titration with the stronger binder. The titrations 
were carried out in 10 mM phosphate buffer, 70 mM KCl, 0.2 mM 
EDTA, 7% DMSO, pH 7, at 298 K. In each experiment, volumes 
of 10 L of a 720 µM distamycin A solution were added into a 30 
M solution of quadruplex-DNA complex, using a computer-
controlled 250-L microsyringe, with a spacing of 200-400 s 
between each injection. 
Figure 5.6a and Figure 5.6b show two representative ITC 
displacement experiments carried out by titrating with distamycin 
A the [d(TGGGGT)]4 G-quadruplex saturated with compounds 
G16 and G2, respectively. The results obtained in the two 
experiments are very different and clearly show two different 
phenomena. In the first case, the ITC profile for the titration of 
ligand-saturated G-quadruplex is essentially identical to the one 
obtained for the binding of distamycin A to the G-quadruplex 
alone, with two distinct binding events, each involving two ligand 
molecules, to give a final 4:1 stoichiometry [95,170], indicating 
that the presence of G16 does not affect the interaction. On the 
contrary, the titration of [d(TGGGGT)]4/G2 mixture with 
distamycin A (b) gives completely different results. In this case, the 
ITC data show constant heat release after each injection of 
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distamycin A, only due to ligand dilution, proving that it is no 
longer able to interact with the G-quadruplex.  
Overall, ITC experiments showed that four out of sixteen 
compounds (G1, G2, G3 and G4) have ability to bind to G-
quadruplex DNA more tightly than distamycin A, inhibiting its 
interaction, whereas the other compounds bind rather weakly to the 
G-quadruplex. To evaluate a possible selectivity of the best ligands 
for the G-quadruplex over duplex, identical ITC displacement 
experiments by titrating with distamycin A the DNA duplex 
d(CGCGAATTCGCG)2 saturated with compounds G1-G4, were 
performed. This self-complementary dodecamer was chosen 
because it contains the central AATT core, which is considered the 
specific binding site for distamycin A  [172]. Examples of raw ITC 
data and binding isotherm for the titration of the 
d(CGCGAATTCGCG)2/G4 mixture with distamycin A are shown 
in Figure 5.6c. As can be seen, at each injection of distamycin A 
solution, less and less heat release was measured until constant 
values were obtained, implying a saturable process. The binding 
isotherm resulting from the integration of raw data shows a typical 
sigmoidal binding curve centered on a 2:1 stoichiometry and 
clearly show that the presence of compounds  G1-G4 in the 
mixture has no effect on the interaction of distamycin A with the 
duplex (Table 5.2). 
 
 
 
Figure 5.6  Raw ITC data (top panels) and normalized heat (bottom panels) for 
titration of  [d(TGGGGT)]4/G16 (a), [d(TGGGGT)]4/G2 (b), and 
d(CGCGAATTCGCG)2/G4 (c) mixtures with distamycin A at 25 °C. The 
normalized heat for the titrations (filled circles) was obtained by integrating the 
raw data and subtracting the heat of the ligand dilution. The lines represent 
nonlinear least squares ﬁt of the data to the appropriate binding model.
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Table 5.2    Thermodynamic parameters for the interaction of Distamycin A with [d(TGGGGT)4] and its complexes formed with the G1-G4 
are not reported since they abolish the binding of Distamycin A; Thermodynamic parameters for the interaction of Distamycin A with duplex 
and its complexes formed with the G5-G16 are not reported since they abolish the binding of Distamycin A. The experimental error for each 
thermodynamic property is <7%
 
 n1 k1 (M
-1
) 
ΔG1 
kJ/mol 
ΔH1 
kJ/mol 
TΔS1 
kJ/mol 
n2 
k2 
M
-1
 
ΔG2 
kJ/mol 
ΔH2 
kJ/mol 
TΔS2 
kJ/mol 
quadrulex/G5 ND ND ND ND ND ND ND ND ND ND 
quadrulex/G6 1.9 5x10
7 
-44
 
-3.0 41 2.1 4.2x10
6
 -38.0 -1.0 37.0 
quadrulex/G7 ND ND ND ND ND ND ND ND ND ND 
quadrulex/G8 1.9 1x10
7 
-39 -8.3 31 2.0 6.0x10
7
 -44.0 -4.2 40 
quadrulex/G9 2.2 3.7x10
7 
-43 -4.0 39 1.9 3.2x10
6
 -37 -1.2 36 
quadrulex/G10 2.0 2.0x10
7
 -42 -4.0 38 1.9 4.0x10
6
 -37 -1.7 36 
quadrulex/G11 1.8 4.0x10
7
 -43 -6.1 37 2.0 6.3x10
6
 -39 -0.6 38 
quadrulex/G12 2.0 4.7x10
6
 -38 -1.5 36 2.0 1.4x10
7 
-40 -4.3 36 
quadrulex/G13 2.1 4.2x10
7
 -44 -4.2 39 1.8 2.3x10
6
 -36 -1.6 34 
quadrulex/G14 1.9 3.2x10
7
 -43 -6.3 37 2.2 5.5x10
6
 -38 -2.0 36 
quadrulex/G15 1.8 4.0x10
7
 -44 -6.5 38 2.2 4.2x10
5
 -32 -4.3 28 
quadrulex/G16 1.9 2.5x10
7
 -42 -3.7 38 2.1 1.6x10
6 
-35 -1.2 34 
distamycin 2.0 9.4x10
6
 -40 -3.9 36 2.0 6.0x10
5
 -33 -1.2 32 
Duplex/G1 ND ND ND ND ND 
 
Duplex/G2 ND ND ND ND ND 
Duplex/G3 1.8 9.0x10
5
 -34 -12 22 
Duplex/G4 2.0 6.0x10
5
 -33 -6 27 
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5.2.2. Discussion and Conclusions 
 
A previous structure-based virtual screening (VS) campaign [169] 
and a subsequent NMR and ITC study [170] resulted in the 
identification of a molecule (compound G1)  able to interact with 
the groove of the quadruplex [d(TGGGGT)]4  stronger than 
distamycin A.  
G1 derivatives were then synthesized by Prof. Novellino from the 
department of Pharmaceutical Chemistry and Toxicology of 
University  of  Naples  “Federico II”.  In  this  context  the aim was 
to evaluate  the interaction  of the ligands for the quadruplex 
[d(TGGGGT)]4 by means of isothermal tritation  calorimetry 
(ITC),  analysing  their  displacement  from  the  grooves  of  DNA-
quadruplex  by   distamycin A,  the best groove binder identified 
until now. The competition ITC experiments represent a possible 
strategy to evaluate the efficiency of a groove binder compared to 
distamycin A.  
The ITC experiments allowed to select four molecules (G1-G4) 
that  bind  [d(TGGGGT)]4  with  greater  affinity  than  distamycin 
A.  As it is widely accepted that specificity for DNA G-
quadruplexes is a fundamental requirement for the quadruplex 
binder to become a drug, binding tests towards DNA duplex have 
been performed. Moreover to test the activity and toxicity of 
ligands  have  been  performed  biological assays by  Dr. Biroccio     
from  the National Cancer Istitute “Regina Elena”. 
The ITC study combined with biological data allowed to select four 
ligands that are more effective in groove binding with respect to 
distamycin A. Compounds G3 and G4 bind to the quadruplex 
structures with higher affinity compared to the duplex DNA. 
Additionally, the biological characterization of the new ligands 
demonstrates their ability to induce selective DNA damage at 
telomeric level and the induction of apoptosis and senescence on 
tumour cells. These results finally demonstrate that induction of 
tumour cell death can be efficiently achieved by compounds able to 
selectively target the G-quadruplex grooves. These results reinforce 
the notion that G-quadruplex binding compounds can act as broad 
inhibitors of telomere-related processes  and  could  represent  
potential  selective antineoplastic  drugs.  This  project  was  
designed  and  developed in  collaboration  with  the  department  
of  Pharmaceutical  Chemistry  and  Toxicology   of  University  of  
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Naples  “Federico II” and the  National  Cancer  Istitute  “Regina 
Elena”  of   Rome.  
  
 109 
 
Concluding remarks 
 
In conclusion, targeting  G-quadruplex-DNA  represents a high 
scientific  challenge since this particular DNA arrangement has 
been found in biologically relevant area of genoma and is less 
abundant as compared to canonical duplex-DNA. In addition, 
ligands able to bind selectively to G-quadruplexes may have 
important  biological  effects  for therapeutic purposes. In 
particular, the  results  obtained quite convincingly pave the way 
for the exploitation  of  G-quadruplex  ligands  as  tools  to evaluate  
the  therapeutic  potential  of  telomeres. 
Indeed, over the past decade, the G-quadruplex ligand field has 
developed exponentially. A glimpse at the advances made in the 
design and the synthesis of G-quadruplex ligands leave us 
convinced  that  the development of compounds able to 
discriminate not only G-quadruplex from duplex-DNA, but 
between  the  various  structures  of  G-quadruplexes  is  imminent.   
In this perspective,  it  is important that investigators aim at a 
deeper understanding of the structural aspects of human telomere 
folding and the energetic aspects of quadruplex-drug molecular 
recognition. Many classic or newly adopted physico-chemical 
techniques can be very useful towards this direction, in  this  field  
ITC is clearly the method of choice to measure the free energy, 
enthalpy,  and  stoichiometry of a quadruplex-drug binding 
reaction. 
Overall research in the field of quadruplex ligands is getting more 
and more exciting as knowledge increases. In the future, G-
quadruplex chemists and biologists acting in conjunction could 
very well provide new molecular principles that  may find 
applications both in molecular and cellular biology and may 
contribute to the development of novel anti-cancer therapies. 
Through the course of my studies as a Ph.D. student, I  hope  to 
have contributed a small piece of a much larger puzzle which in 
turn may help the future of cancer research. 
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1. Martino L., Pagano B., Fotticchia I., Neidle S., Giancola 
C., Shedding light on the interaction between TMPyP4 
and human telomeric quadruplexes, J Phys Chem B., 
2009,113(44):14779-86. 
 
Abstract 
The nature of the binding mode and stoichiometry of the 
TMPyP4 cationic porphyrin to G-quadruplex structures 
continues to be controversial, with no consensus model to 
date, especially for intramolecular G-quadruplexes from 
human telomeric sequences. Those sequences possess 
intricate polymorphism in solution that appears to be 
reduced under molecular crowding conditions in which the 
parallel structure appears to be the most populated one. We 
have performed a systematic study, in dilute solution and 
under molecular crowding conditions, of the binding 
reactions between TMPyP4 and four G-quadruplexes 
formed by different truncations of human telomeric DNA, 
with 5'- or 3'-flanking bases, using isothermal titration 
calorimetry and circular dichroism. The results clearly 
indicate that all of these G-quadruplexes are able to bind up 
to four TMPyP4 molecules. CD studies show that 
interaction with TMPyP4 promotes the conversion of the 
hybrid structures to an antiparallel conformation in dilute 
solution, while under molecular crowding conditions the 
interaction does not promote any conformational change. 
ITC reveals in both cases that the binding process 
comprises two sequential events, a first in which one 
molecule of TMPyP4 interacts with the quadruplex 
structures and a second in which three other molecules bind 
to the structures. The selectivity of TMPyP4 for the 
quadruplex relative to duplex DNA was also investigated 
under molecular crowding conditions showing that 
TMPyP4 has enhanced selectivity for quadruplex DNA 
compared to the duplex structure. This finding reinforces 
the potential applications of TMPyP4. 
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2. Pagano B., Fotticchia I., De Tito S., Mattia C.A., Mayol L., 
Novellino E., Randazzo A., Giancola C., Selective Binding 
of Distamycin A Derivative to G-Quadruplex Structure 
[d(TGGGGT)]4,  J Nucleic Acids., 2010, 30. 
 
Abstract 
Guanine-rich nucleic acid sequences can adopt G-
quadruplex structures stabilized by layers of four 
Hoogsteen-paired guanine residues. Quadruplex-prone 
sequences are found in many regions of human genome and 
in the telomeres of all eukaryotic organisms. Since small 
molecules that target G-quadruplexes have been found to be 
effective telomerase inhibitors, the identification of new 
specific ligands for G-quadruplexes is emerging as a 
promising approach to develop new anticancer drugs. 
Distamycin A is known to bind to AT-rich sequences of 
duplex DNA, but it has recently been shown to interact also 
with G-quadruplexes. Here, isothermal titration calorimetry 
(ITC) and NMR techniques have been employed to 
characterize the interaction between a dicationic derivative 
of distamycin A (compound 1) and the [d(TGGGGT)](4) 
quadruplex. Additionally, to compare the binding behaviour 
of netropsin and compound 1 to the same target, a 
calometric study of the interaction between netropsin and 
[d(TGGGGT)](4) has been performed. Experiments show 
that netropsin and compound 1 are able to bind to 
[d(TGGGGT)](4) with good affinity and comparable 
thermodynamic profiles. In both cases the interactions are 
entropically driven processes with a small favourable 
enthalpic contribution. Interestingly, the structural 
modifications of compound 1 decrease the affinity of the 
ligand toward the duplex, enhancing the selectivity. 
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3. Giancola C., Ercole C., Fotticchia I., Spadaccini R., Pizzo 
E., D'Alessio G., Picone D., Structure-cytotoxicity 
relationships in bovine seminal ribonuclease: new 
insights from heat and chemical denaturation studies on 
variants, FEBS J., 2011, 278(1):111-22.  
 
Abstract 
Bovine seminal ribonuclease (BS-RNase), a homodimeric 
protein displaying selective cytotoxicity towards tumor 
cells, is isolated as a mixture of two isoforms, a dimeric 
form in which the chains swap their N-termini, and an 
unswapped dimer. In the cytosolic reducing environment, 
the dimeric form in which the chains swap their N-termini 
is converted into a noncovalent dimer (termed NCD), in 
which the monomers remain intertwined through their N-
terminal ends. The quaternary structure renders the reduced 
protein resistant to the ribonuclease inhibitor, a protein that 
binds most ribonucleases with very high affinity. On the 
other hand, upon selective reduction, the unswapped dimer 
is converted in two monomers, which are readily bound and 
inactivated by the ribonuclease inhibitor. On the basis of 
these considerations, it has been proposed that the cytotoxic 
activity of BS-RNase relies on the 3D structure and stability 
of its NCD derivative. Here, we report a comparison of the 
thermodynamic and chemical stability of the NCD form of 
BS-RNase with that of the monomeric derivative, together 
with an investigation of the thermal dissociation mechanism 
revealing the presence of a dimeric intermediate. In 
addition, we report that the replacement of of Arg80 by Ser 
significantly decreases the cytotoxic activity of BS-RNase 
and the stability of the NCD form with respect to the parent 
protein, but does not affect the ribonucleolytic activity or 
the dissociation mechanism. The data show the importance 
of Arg80 for the cytotoxicity of BS-RNase, and also 
support the hypothesis that the reduced derivative of BS-
RNase is responsible for its cytotoxic activity. 
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4. Cummaro A., Fotticchia I., Franceschin M., Giancola C., 
Petraccone L., Binding properties of human telomeric 
quadruplex multimers: a new route for drug design., 
Biochemie, 2011, 93(9):1392-400. 
 
Abstract 
Human telomeric G-quadruplex structures are known to be 
promising targets for an anticancer therapy. In the past 
decade, several research groups have been focused on the 
design of new ligands trying to optimize the interactions 
between these small molecules and the G-quadruplex motif. 
In most of these studies, the target structures were the single 
quadruplex units formed by short human DNA telomeric 
sequences (typically 21-26 nt). However, the 3'-terminal 
single-stranded human telomeric DNA is actually 100-200 
bases long and can form higher-order structures by 
clustering several consecutive quadruplex units 
(multimers). Despite the increasing number of structural 
information on longer DNA telomeric sequences, very few 
data are available on the binding properties of these 
sequences compared with the shorter DNA telomeric 
sequences. In this paper we use a combination of 
spectroscopic (CD, UV and fluorescence) and calorimetric 
techniques (ITC) to compare the binding properties of the 
(TTAGGG)(8)TT structure formed by two adjacent 
quadruplex units with the binding properties of the 
(AG(3)TT)(4) single quadruplex structure. The three side-
chained triazatruxene derivative azatrux and TMPyP4 
cationic porphyrin were used as quadruplex ligands. We 
found that, depending on the drug, the number of binding 
sites per quadruplex unit available in the multimer structure 
was smaller or greater than the one expected on the basis of 
the results obtained from individual quadruplex binding 
studies. This work suggests that the quadruplex units along 
a multimer structure do not behave as completely 
independent. The presence of adjacent quadruplexes results 
in a diverse binding ability not predictable from single 
quadruplex binding studies.  
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5. Petraccone L., Fotticchia I., Cummaro A., Pagano B., 
Ginnari-Satriani L., Haider S., Randazzo A., Novellino E., 
Neidle S., Giancola C., The triazatruxene derivative 
azatrux binds to the parallel form of the human 
telomeric G-quadruplex under molecular crowding 
conditions: biophysical and molecular modeling studies, 
Biochemie, 2011, 93(8):1318-27 
 
Abstract 
The present study has employed a combination of 
spectroscopic, calorimetric and computational methods to 
explore the binding of the three side-chained triazatruxene 
derivative, termed azatrux, to a human telomeric G-
quadruplex sequence, under conditions of molecular 
crowding. The binding of azatrux to the tetramolecular 
parallel [d(TGGGGT)](4) quadruplex in the presence and 
absence of crowding conditions, was also characterized. 
The data indicate that azatrux binds in an end-stacking 
mode to the parallel G-quadruplex scaffold and highlights 
the key structural elements involved in the binding. The 
selectivity of azatrux for the human telomeric G-quadruplex 
relative to another biologically relevant G-quadruplex (c-
Kit87up) and to duplex DNA was also investigated under 
molecular crowding conditions, showing that azatrux has 
good selectivity for the human telomeric G-quadruplex over 
the other investigated DNA structures. 
 
